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Abstract
The thesis describes algorithms for detecting regions of recent identity
by descent (IBD) from human genetic data and its applications in
optimising resequencing studies, genomic predictions and detecting
Mendelian subtypes of diseases.
Firstly, we describe the algorithm ANCHAP, which scans pairs of
multi-point SNP genotypes for sharing IBD of long haplotypes. A
comparison with other methods shows that ANCHAP outperforms
them in terms of speed or accuracy. We demonstrate the algorithm
on data from population isolates - from Orcades, Croatian islands,
and from a population of unrelated individuals. We compare the
abundance of IBD segments between cohorts, and identify genetic
regions where IBD is most common.
Secondly, we verify the IBD regions detected from array data against
exome sequence data. We estimate that where sharing IBD between
a pair of individuals is inferred, this is confirmed by exome data in
98% of cases. Correctness of IBD detection varies with settings of
ANCHAP, length of IBD segments, and position with respect to seg-
ment endpoints. We find that with sample sizes of 1000 individuals
from an isolated population genotyped using a dense SNP array, and
with 20% of these individuals sequenced, 65% of sequences of the un-
sequenced subjects can be partially inferred. Implementation of such
resequencing strategies requires an IBD-based imputation algorithm,
which is outlined.
Thirdly, we use recent IBD to detect carriers of Mendelian subtypes
of colon cancer. We show this with the example of Lynch syndrome,
which accounts for about 3% of colon cancer patients. We detect IBD
sharing between known and unknown carriers around DNA mismatch-
repair genes. Using the IBD relationship, we build and evaluate a
model that predicts presence of Lynch Syndrome mutations.
Finally, we discuss whether regions of identity by descent can be used
for genomic predictions. We conclude that the utility of the inferred
IBD regions depends on accuracy of detection, time to most recent
common ancestors and mutation rates since.
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1.1 Motivation and aims
We first present an idea that connects the parts of the thesis, and then outline
the scientific, technological and historical background behind it.
The idea behind the work presented in this thesis is to tag rare variants in
genetic data through long-range haplotypes. Rare genetic variants could explain
some of the missing heritability of diseases and quantitative traits. Due to allelic
heterogeneity, single nucleotide polymorphisms (SNPs) may not tag rare variants,
however the rare variants would be likely captured by long-range haplotypes.
Long identical-by-descent (IBD) haplotypes are more likely to occur in isolated
populations, where due to geographical isolation and constrained population size
any two individuals are likely to have a recent ancestor. Resulting from the
relatedness are long haplotypes shared IBD, which can be recovered from SNP
data by algorithms.
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Figure 1.1: An ancestral haplotype shared IBD in current generation. The an-
cestral haplotype, depicted in black, was shortened by recombination events as it
was passed through generations towards bottom of the figure. Where cross-overs
did not occur, current generation of individuals (C1-C8) share the haplotype IBD
around locus x. Source: (Morris et al., 2002)
Genetically isolated populations result from ”the founder effect of a small
number of individuals as a consequence of some type of bottleneck. They exist in
geographical, cultural, or geographical and cultural isolation over many genera-
tions without genetic interchange from other subpopulations” (Arcos-Burgos and
Muenke, 2002). In isolated populations most individuals share relatively recent
common ancestors. If more than one individual inherited the same ancient haplo-
type in a region, we call them haplotype sharers. Segments of their chromosomes
are identical by descent - their haplotypes ”descend from a common ancestor
without either of them experiencing a recombination” (Powell et al., 2010). The
concept of sharing IBD of an ancestral haplotype is depicted in Figure 1.1. While
any two copies of an allele are identical by descent with a recent common ances-
tor in the remote past, where longer stretches have been inherited, the common
ancestor is likely to have been more recent. Although there is a continuum be-
tween recent and ancient sharing, we distinguish recent IBD from the ancient one
based on length of segments shared IBD. While SNP arrays do not directly reveal
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gametic phase, haplotype sharers can be identified using computational methods.
Applications of inference of regions of identity by descent include:
1. mapping genetic effects on complex traits,
2. optimization of resequencing studies
3. genomic predictions,
4. studying Mendelian subtypes of diseases.
In the first application, inference of shared haplotypes may make it possible to
detect the effects of genes in which functional variants that are rare in the general
population have drifted to high frequency in the isolated population. Further-
more, the reduced allelic heterogeneity in an isolate provides an opportunity to
detect associations with these otherwise rare variants. In an outbred population
conventional GWAS studies may fail to detect associations with rare variants, as
these may not be in linkage disequilibrium with SNPs on genotyping arrays that
have been optimized to tag common variants (Johnson et al., 2001; Terwilliger
and Weiss, 1998). In genetically isolated populations like Iceland or Finland the
linkage disequilibrium may be higher. Examples of diseases which were linked to
genetic loci in studies of isolates include: myocardial infarction, stroke, type 2 dia-
betes, atrial fibrillation, prostate cancer, schizophrenia and asthma (Kristiansson
et al., 2008). The uncovered ancestral haplotypes can be in even stronger asso-
ciation with rare functional variants and hence improve the power of association
tests. The most ambitious attempts to map effects of shared haplotypes recon-
struct descent trees, but this approach has been found computationally infeasible
(Morris et al., 2002).
In the second application, when SNP genotypes are available and next-generation
sequencing is planned, exploiting haplotype sharing between individuals can save
resources. With sharing inferred from SNP genotypes, it is possible to choose a
minimally redundant subset of individuals to be sequenced, and then to impute
sequence data into other subjects with SNP genotype data.
In the third application, IBD segments could be used in models for genomic
predictions. They should be most effective when traits being predicted are af-
fected by rare genetic variants.
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In the fourth application, IBD segments could be used for studying Mendelian
subtypes of diseases. Around each causal mutation the carriers are likely to
share haplotypes even in out-bred populations, and depending on the time to
the recent common ancestor the shared segments could be long. Carriers of the
same Mendelian subtypes could be identified through IBD analysis on SNP data.
Identifying carriers of Mendelian subtypes of diseases is a real clinical problem,
for example in colon cancer, where patients who carry Mendelian forms of the
disease are often not correctly diagnosed and accordingly do not receive the most
appropriate treatment.
1.1.1 Aims
The aims of the project were:
• to develop an algorithm for detecting recent identity by descent from SNP
data,
• to compare it against existing methods,
• to use detected IBD haplotypes for optimisation of resequencing study in
an isolated population,
• to develop and test a method for detecting patients of carrying Mendelian
subtypes of diseases, such as Lynch syndrome in colon cancer,
• to evaluate utility of IBD segments for genomic predictions.
1.2 Genotyping and sequencing technology
Recent developments in genotyping and sequencing technologies present excit-
ing opportunities for understanding genetic cause of diseases, and for verifying
population-genetics models against large-scale data sets. SNP genotyping is grad-
ually giving way to next-generation sequencing technologies, which are being em-
ployed in increasingly larger studies.
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1.2.1 SNP arrays
The HapMap project (Consortium, 2007) characterised single nucleotide polymor-
phisms of 270 individuals from African, Asian and European ancestry. Identified
and verified were 3.1 million variants with frequency at least 0.05 (Stranger et al.,
2011). Once identified, the SNPs are used to design genotyping arrays. Primers
for the SNPs are bound to a chip, such that SNPs can be identified by their posi-
tions on a plate (Syvänen, 2001). Segmented and amplified fragments of a DNA
segments hybridise to the primers, after which fluorescent-marked nucleotides
attach to sample fragments, and different nucleotides are marked with different
colours. Decoding genotypes at SNPs on an array involves analysis of an image,
in which different colours of light denote different nucleotides.
1.2.2 Next-generation sequencing
The development of sequencing technology led to discovery of 10 million new
variants in the 1000 Genomes project (Consortium, 2012). Next-generation se-
quencing, irrespective of specific technology, consists of template preparation,
sequencing and imaging (Metzker, 2009; Nekrutenko and Taylor, 2012). Firstly,
a sample of DNA is fragmented to produce templates. These are immobilised
to a solid surface or support, and clonally amplified through polymerase chain
reaction. Many clusters of identical single-stranded templates are produced, and
are gathered close together to facilitate sequencing. Sequencing is done for many
amplified templates simultaneously to speed up the process. Sequencing is ini-
tiated by adding known primers, after which nucleotides hybridise to the tem-
plates. These are often dyed (Solexa platform), or their inclusion can be detected
through light the inclusion of nucleotides produces (Roche 454). A template
is read through analysis of images from cameras attached to sequencing plates.
In subsequent analysis template reads are aligned against the reference human
genome, and variants from the reference are detected.
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1.3 Mapping of disease and trait-associated ge-
netic loci
The emergence of technology for reading DNA poses an exciting opportunity for
understanding genetic diseases. Such knowledge could be used for understanding
their molecular basis or estimating individuals’ risk for developing the conditions.
The following section presents the methods for identifying genetic loci where
variants are associated with traits and diseases.
1.3.1 Family-based linkage studies
Linkage analysis is a way of localising genetic loci that predispose to disease with
respect to a set of known genetic markers (Teare and Barrett, 2005). Linkage
studies require families with multiple affected members, knowledge of genotypes
at genetic markers in the family and a pedigree. Estimate of genetic position of
a disease-causing locus comes from maximising the LOD score (Morton, 1956).
The LOD score is calculated as a logarithm of the ratio of likelihood of the data
given a disease locus at a genetic position to the likelihood of the data given
no linkage with the locus. A major problem with linkage studies is reduced
power when there are many genes associated with a disease and they are of
small effect. Nevertheless, genes for disorders affected by several genes have
been mapped with linkage analysis, for example BRCA1 and BRCA2 for breast
cancer. Another limitation is that resolution of mapping in this way is limited
to tens of centiMorgans, depending on the number of informative meioses in a
pedigree. Finally, linkage analysis has only been effective for simple diseases with
large risk-ratios for different genotypes. Building a genetic model for parametric
linkage studies requires knowledge of mode of inheritance of a disease, disease
allele frequency and penetrance, some of which may be unknown.
Major gene disorders are amenable to parametric linkage analysis, because the
disease allele frequencies and penetrance can be estimated in advance. For com-
plex diseases, non-parametric methods have been used but there have been rel-
atively few successes in discovering disease susceptibility genes. Non-parametric
linkage methods involve testing of increased IBD sharing among relatives, in cer-
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tain genomic regions. These tests can be pair-wise, between siblings, but also
exploit larger pedigrees. Simplest tests would look for excess IBD sharing com-
pared to expected due to relatedness at a single locus at a time, while more
complex ones would attempt to map the genes throughout the chromosomes. An
advantage of linkage studies in comparison with association mapping is that they
are not affected by allelic heterogeneity.
1.3.2 Genome-wide association studies
Linkage analysis has little chance of success with complex diseases which could
be affected by variants of modest effect in multiple genes, because the power of
the method is heavily reduced when little of trait variance is explained (Sham
et al., 2000). In order to dissect genetic mechanisms that drive diseases and com-
plex traits, genome-wide association studies analyse genetic data from unrelated
individuals who share at most short haplotypes around causal variants. Genome-
wide association studies (GWAS) assume that the causal variants can be tagged
by single-nucleotide polymorphisms (SNPs), at which the samples are genotyped
(McCarthy et al., 2008). In GWAS genotypes at each SNP individually are tested
for association with a disease or trait, through linear or logistic regression.
GWAS studies have identified many disease-associated loci, but the associa-
tions detected at genome-wide significance level account for only a small propor-
tion of estimated genetic variance, as estimated from phenotypic resemblances
between relatives. This is the ’missing heritability’, which limits the potential for
individual disease risk prediction (McCarthy et al., 2008). Missing heritability
could arise from allelic heterogeneity. Multiple causal variants may not be tagged
by genotyped SNPs (Terwilliger and Weiss, 1998). Some of the problem with
allelic heterogeneity can be dealt with through choice of samples, for example
through choosing distantly related familial cases. Finally, the problem of allelic
heterogeneity in GWAS could be addressed through increasing coverage of vari-
ation on genotyping arrays, so that typed markers are correlated with the causal




Allelic heterogeneity of complex diseases and traits can be reduced by studying
isolated populations (Peltonen et al., 2000). Population isolates may be generated
either by prolonged constraint of population size or by a founder effect. Genetic
drift and population bottlenecks reduce genetic complexity of individuals. Ge-
netic variants that are rare in general population may become more frequent, and
they may be better tagged by SNPs on genotyping arrays. Association studies
may be further facilitated for diseases particularly common in an isolate, also
because environmental factors and cultural features are more uniform than in
general population.
Two widely studied isolated populations are Finland and Iceland. The major-
ity of Finns descended from migration waves 4000 and 2000 years ago, and since
then formed several sub-isolates around the country. Iceland was settled around
1000 years ago by immigrants from Norway, Ireland and Scotland, and since then
received few newcomers.
Population isolates offer reduced allelic heterogeneity, increased frequency of
some diseases and uniform exposure to environmental factors. While reduced
genetic complexity of individuals in isolates may facilitate association studies, it
also means that the associations found may not generalise to wider population.
1.3.4 Linkage disequilibrium studies
Linkage disequilibrium studies assume that affected individuals share a region of a
chromosome around the causal variant, because they all co-inherited a haplotype
on which the mutation occurred. This is more likely in a population isolate,
where due to migration constraints any two carriers are likely to have a recent
common ancestor, and where genetic heterogeneity of diseases is reduced. A
linkage disequilibrium study in the isolated population of Finland localised a gene
associated with diastrophic dysplasia (Hastbacka et al., 1992). Studied were 77
Finnish families where the disease segregated. Initially, 20 markers of chromosome
5 had been shown to be in linkage with the diseases, and the following linkage
disequilibrium study focused on haplotypes at these markers. At a 2 consecutive
markers 95% of individuals affected by disease shared a haplotype, from which it
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was inferred that the causal variant was within as little as 0.06 cM.
The linkage disequilibrium study narrowed down the position of the causal
variant from a region of 1.6 cM which had previously been established by linkage
analysis. The linkage disequilibrium study took advantage of many more informa-
tive recombinations that occurred in the whole isolate, in comparison to within
affected families. The approach treated all Finnish carriers as a big, distantly
related family.
1.3.5 Coalescent model
Linkage disequilibrium between genetic loci arises because of history of mutation,
recombination and coalescence of lineages. Alleles on the same haplotypes are
statistically dependent because of genetic linkage, and there is dependence be-
tween haplotypes due to shared ancestry. The coalescent is a stochastic process
that enables modelling history behind genetic polymorphism data (Rosenberg
et al., 2002).
The Kingman’s coalescent is an approximation which allows a computation
of probability of a genealogical tree for each genetic locus. At the bottom of the
tree are alleles in samples studied, which coalesce in the past to form lineages.
All lineages within a sample coalesce at the time when the most recent common
ancestor (MRCA) lived, from which all samples inherited an allele. Mutation at a
locus might have occurred at some point in the past, so that all lineages descend-
ing from an ancestor for which it occurred, carry the variant. The Kingman’s
coalescent allows computation of probabilities of ancestral trees. The lineages
under study randomly choose other lineages to coalesce with, at times in the past
dependent on number of lineages. The rate at which they coalesce depends on
the number of samples in the study and number of lineages at each point in the
past. Eventually all lineages coalesce to their MRCA.
Recombination events that gave rise to haplotypes in the studied samples also
affect coalescent trees. Coalescent trees at neighbouring loci are will be distinct if
recombination occurred between neighbouring haplotypes. The extent to which
two coalescent trees between neighbouring sites are similar will be affected by
recombination rates in the region. When few cross-overs occur, this will manifest
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itself as linkage disequilibrium in the genetic region.
The coalescent model can be used for building simulations, or estimating
parameters of history of a population studied. With the coalescent it is possible
to compare fit of different history models with the genetic polymorphic data.
This involves summing over all possible models of the past, which however is
computationally very demanding.
1.3.6 Shattered coalescent
One of uses of the coalescent model is fine-mapping of disease loci (Morris et al.,
2002). Morris et al. described a method for inference of location of a causal
disease locus from case-control haplotypes from an implicated region. The idea
is the same as in linkage disequilibrium studies, namely that disease haplotypes
in the neighbourhood of the causal variant are all the same, and descend from
same branches of the coalescent tree.
In an effort for disease fine-mapping, the authors specify a fully Bayesian
model of case-control haplotypes, with a prior probability on coalescent trees
which connect them. Adjacent neighbouring trees are linked by recombination
events, which in a simplified way are also included into the coalescent model. An
important innovation is allowing the tree to coalesce to multiple roots rather than
one common ancestor, from which the name ’shattered coalescent’ is derived. In
this way, the model can account for multiple mutations affecting the disease and
sporadic occurrence of a diseases, for example due to genes outside of the studied
region.
Morris et al. studied 92 control 94 case chromosomes from patients affected by
cystic fibrosis, a disease whose genetic background is well understood. 23 markers
in a previously implicated region on chromosome 7 entered the analysis. As a
result of applying the method, the most likely associated causal locus coincided
closely with a variant known to be a causal one. As a further benefit of modelling
the coalescent trees, estimated was also time to common ancestor of the cystic
fibrosis mutation. However, the computational cost of Bayesian analysis turned
out to be very large - analysis with only 23 markers took 2 days of computation
on a personal computer. Similar large-scale analysis of more complex disease may
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be prohibitively demanding, because computation time scales exponentially with
depth of descent tree
1.3.7 Fragmentation-coagulation process
Coalescent trees are one way of modelling haplotypes found in genetic data, how-
ever other more tractable methods have been developed. The other methods
group haplotypes into clusters throughout the genome, such that all haplotypes
in a cluster descended from a common ancestor. The methods represent the
haplotypes as a mosaic of ancestral haplotypes.
One example of such a mosaic-based model is the Fragmentation-Coagulation
Process (Teh et al., 2011), which is illustrated in Figure 1.2. Because this is a
Bayesian non-parametric model, the number of haplotype clusters can adjust to
data in each genetic region. Haplotypes in study change their cluster memberships
throughout genetic regions. In coagulation event all haplotypes from a cluster
join another one, and other clusters may fragment into several clusters. Coupling
this prior haplotype model with a data-likelihood, various types of inference can
be performed, for example allele imputations.
Inference on the Fragmentation-coagulation process requires Monte-Carlo Markov
Chain sampling, which is computationally demanding for large data sets. The
computational time required by the algorithm is proportional to number of clus-
ters of haplotypes in data, so limiting the maximum number of haplotype clusters
at a locus simplifies inference. Several phasing algorithms are based on this idea,
typically using hidden Markov models, as outlined in further sections.
1.4 Phasing algorithms
The aim of phasing algorithms is to reveal haplotypes in genotype data. Short-
range HMM-based methods rely on linkage disequilibrium between neighbouring
genetic loci, whereas long-range methods depend on long haplotypes shared be-
tween distantly related samples.
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Figure 1.2: Fragmentation Coagulation Process, a Bayesian non-parametric
model for haplotypes. Six different haplotypes are modelled in the genetic re-
gion between 0 and T . At loci marked with C the clusters merge, where marked
by F the clusters split. Probabilities of these events depend on cluster sizes.
Source: (Teh et al., 2011).
1.4.1 Short-range HMM-based methods
All of the discussed short-range phasing methods rely on the the idea that hap-
lotypes of a new sample are noisy copies of haplotypes among other samples
(Browning and Browning, 2011b). They form a mosaic of the reference hap-
lotypes, as a result of recombination events that occurred since their common
ancestor. Additionally, the sample and reference haplotypes can differ at indi-
vidual loci, which is a trace of mutational process. Because the methods allow
for recombinations and mutations between haplotypes, they are called coalescent-
based.
The phasing programs connect the observed input genotypes with haplotype
models through hidden Markov models (HMM). HMMs are sequential models of
data with hidden structure, appropriate for the application because genetic loci
are linked by linkage and linkage disequilibrium. Visible states correspond to
input genotype data, whereas hidden states correspond to the underlying hap-
lotypes, either to the particular reference haplotypes in some phasing programs,
or to modal haplotypes. Transition probabilities between hidden states represent
recombination rates, and will likely depend on genetic map in a region. Emission
probabilities, which link hidden states and the input genotypes, enforce a match
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between inferred haplotypes and the data, and to some extent model mutation
between reference and sample haplotypes. The output haplotypes are a result of
inference with HMMs, returning the most likely haplotypes given the data. The
algorithms typically require several iterations, initially starting with random hap-
lotypes, at each iteration improving the haplotype estimates. The phasing pro-
gram PHASE is an exception (Stephens et al., 2001), because instead of an HMM
it uses an Expectation-Maximisation (EM) algorithm which does not model the
local structure of haplotypes. Instead, PHASE uses a coalescent-inspired model
of possible haplotypes out of already known ones, and makes haplotypes hidden
variables whose most likely values are inferred by the EM algorithm.
The HMM-based phasing programs differ in how they model possible haplo-
types. FastPHASE models haplotypes as belonging to one of a very limited
number of clusters throughout genomic locations (Scheet and Stephens, 2006).
For each of the clusters and at each locus, haplotype alleles are assumed to come
from a binomial distribution whose parameters are estimated. The number of
clusters is chosen by cross-validation, guided by imputation accuracies. The rec-
ommended number of clusters is 8, which limits the chance of the cluster to
convey long-range dependencies between loci. MACH and IMPUTE, rather
than modelling haplotype clusters, as hidden states take haplotypes that have
been estimated for other individuals in previous iterations or from a reference
panel (Howie et al., 2009; Li et al., 2010; Marchini et al., 2007). In HMMs large
number of hidden states make inference harder, so both MACH and IMPUTE re-
duce their numbers. As hidden states MACH uses a random subset of haplotypes,
whereas IMPUTE chooses haplotypes that are globally most similar to a current
estimate of haplotypes for a proband. Instead of using haplotypes from other
samples, Beagle utilizes the localized haplotype cluster model as a parsimonious
empirical LD model (Browning and Browning, 2007). The haplotype model is
built from haplotypes reconstructed so far for other samples, and the complexity
of the haplotype model through genetic regions can vary with complexity of the
haplotypes. Limiting the number of hidden states is very important, since com-
plexity of inference on HMMs scales quadratically with number of hidden states,
which becomes prohibitive with sizes of samples currently becoming available.
The main advantage of ShapeIT, another phasing program is that complexity of
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its computation scales linearly with the number of samples in a study (Delaneau
et al., 2011). The algorithm represents haplotypes as a graph structure, whose
space is limited to a constant for each marker. Based on the graph is an HMM,
which despite its state space conveys information about all of the haplotypes.
Furthermore, the sampling of haplotypes consistent with the genotypes is also
simplified. The method splits the genome into smaller regions containing only a
few heterozygous markers, and in each of these regions the allowed haplotypes
are enumerated. At the region borders the haplotypes are allowed to switch their
state membership. The recently described algorithm of ShapeIT2 uses a similar
representation of haplotypes and inference, however it improves phasing accuracy
through an idea borrowed from IMPUTE (Delaneau et al., 2012). When inferring
haplotypes for a sample, the algorithm is guided by several haplotypes of other
samples globally most similar to a proband. This improves the phasing accuracy
and the chance of haplotypes being correct across longer genetic regions. In sum-
mary, obtaining scalability of phasing algorithms relies on making compressed
representations of haplotypes as hidden states of HMMs.
1.4.2 Long-range phasing methods
Long-range phasing methods rely on long identical-by-descent haplotypes inher-
ited from common ancestors of any pair. They do not model or simplify the
haplotypes, which often increases phasing accuracy. The first rule-based algo-
rithm for long range phasing was described by Kong et al. (Kong et al., 2008a,
2009) and is similar to the method presented later by Hickey et al. (Hickey et al.,
2011). The principle behind these methods is explained in Figure 1.3. Both of
these algorithms detect IBD sharing only in pre-specified genetic regions, identi-
cal for all pairs of compared multi-point genotypes, whereas in reality boundaries
of IBD regions can occur anywhere across the genome. Further implementations
and improvements were brought by Palin et al. (Palin et al., 2011) through
Systematic Long Range Phasing (SLRP).
Systematic Long Range Phasing (SLRP) is a fully probabilistic model for
phasing and IBD detection in isolated populations. The Bayesian network in
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Figure 1.3: Principle by which IBD sharing is inferred from SNP data in the
algorithm described by Kong et al.
Multi-point genotypes at consecutive SNPs are shown for two individuals. Minor
alleles are denoted by lower-case letters, while major alleles by capital letters.
No haplotype could be shared between the two samples at loci with opposing
homozygotes, i.e. at the ”bb/BB” locus and the ”HH/hh” locus. Where there is
a long region without opposing alleles, IBD sharing of a haplotype is inferred.
integrates detection of IBD and phasing, so that they are done simultaneously.
Inference of phase and the regions of IBD sharing is done through loopy be-
lief propagation, a special case of the sum-product algorithm for factor graphs
(Kschischang et al., 2001). Maximum-a-posteriori configuration is arrived at af-
ter many iterations, in each of which nodes adjacent in the Bayesian network
send messages one to another. In networks without loops this procedure finds an
exact solution, however in networks with loops like SLRP the algorithm is not
guaranteed to converge to an optimal solution. The authors limit the number of
iterations of the algorithm to 30, and according to their experiments the messages
sent always converge before then.
The computational complexity of the loopy belief propagation in SLRP scales
quadratically with number of individuals in the study, and linearly with the
number of SNPs and iterations. The authors of SLRP took steps to decrease
the computational load. The belief propagation algorithm is applied only to such
parts of the network where pre-processing identifies possible IBD sharing. The
set of putative IBD regions can be pruned, as typically only few haplotype sharers
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are required for phasing. Furthermore, the genome can be divided according to
the putative IBD regions, so that the algorithm can proceed independently in
each of the regions and chromosomes. Finally, the implementation of SLRP had
been prepared for parallel processing.
At the time I started the project only the method by Kong et al. was available.
SLRP is the most recent, thorough and elegant method for long-range phasing,
and it is against this method I will compare my method described in further
sections. Another motivation for developing my long-range program was that
implementation of Long Range Phasing was not published.
1.5 Algorithms for detecting and analysis of IBD
segments
For several applications described in this thesis the purpose is not phasing, but
rather obtaining IBD segments where two individuals share long haplotypes IBD.
Often, like in the case of SLRP algorithm, the IBD segments are a by-product,
since they are used for phasing (Palin et al., 2011). Other methods for detection
of IBD segments use short-range phasing methods, and then attempt to correct
for likely phasing errors.
Two examples of such programs are fastIBD and GERMLINE (Browning and
Thompson, 2012; Gusev et al., 2009). Both algorithms are based on the same idea.
They first use short-range phasing methods to obtain estimates of haplotypes,
and then check for match of haplotypes between samples. Next, they extend the
matches where possible, correcting for phasing errors. Both of the methods score
the likelihood of true IBD sharing in a region. The difference between fastIBD
and GERMLINE is that the former uses Beagle haplotyping algorithm internally,
whether GERMLINE expects pre-phased haplotypes as input.
Methods for analysis of the inferred IBD segments have also been described.
The effectiveness of localising genetic variants with fastIBD was described for
case-control studies (Browning and Thompson, 2012). Statistical methods as-
sessed whether cases of a disease share IBD more often than controls, which is
reminiscent of non-parametric linkage studies. The power of the approach was
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evaluated using simulation, which showed that IBD analysis for populations with
a very recent bottleneck is more powerful than SNP association analysis. They
conclude that if the founding event for a population studied is very recent, IBD
analysis should be preferred over conventional association studies, particularly
with large samples sizes where rare variants would accumulate. For older popula-
tions without such history the result no longer holds. Using fastIBD, the authors
search for IBD associations with type I diabetes, in the Wellcome Trust Case
Control data. They find that conventional association studies found more signif-
icant associations than the IBD analysis. They conclude that IBD analysis could
still be beneficial with larger sample sizes. However, in larger studies it is likely
that data will come from several different genotyping platforms, in which case
accurate IBD detection would be more challenging.
Another method for analysis of IBD segments is named DASH (Gusev et al.,
2011). The method corrects potentially noisy IBD segments with graph-theoretical
approach, and checks for associations of IBD clusters with diseases. IBD clus-
ters could be in closer associations with diseases than SNPs, because the latter
may not be sufficiently correlated with the functional variants. The authors use
identical-by-descent regions as proxies for recent variants. IBD segments are
first recovered from genotype data using GERMLINE, and errors are corrected
through graph theoretical methods. Transitivity of IBD means that if haplotype
A is identical to B and B is identical to C, then A should be identical as C.
Although in theory the IBD relationship should be transitive, imperfect detec-
tion of recently co-inherited regions may remove this property. The algorithm
restructures the IBD relationship so that it becomes transitive, and the graph
representing it consists of fully connected components. For each IBD cluster, the
method computes a likelihood ratio between it being a true cluster, where all
individuals share IBD with each other, and of the cluster being spurious, where
IBD sharing between the members of the group is due to noise. They translate
the principle of likelihood into density of a graph, and propose an algorithm for
finding optimal sub-graphs. The output of the method is clustering of haplo-
types, which can potentially be different at each locus. The resulting clusters are
checked for associations with quantitative traits, and in particular whether they
carry more signal than individual markers typed in the nearby regions.
17
1.6 Outline of the thesis
We have described methods and technology for localising genetic loci associated
with traits and diseases. At the core of theses methods is the coalescent model,
according to which haplotypes containing disease haplotypes have been inherited
from a common ancestor.
In the subsequent chapters we describe a novel long-range haplotyping method
and its application to resequencing studies, to understanding diseases with Mendelian
subtypes and to genomic predictions.
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Chapter 2
Inference of identity by descent
in genetically isolated
populations
Data from large genetic studies of population isolates was generated in my group,
with intention of studying effects of rare variants. SNP genotypes became avail-
able for around 1000 individuals each from Scottish archipelago of Orkney and
from Croatian islands of Vis and Korcula. Long-range phasing was then first de-
scribed (Kong et al., 2008b), but no implementation was available. My aim was to
develop an algorithm capable of correctly recovering long-range haplotypes and
of detecting regions of haplotypes shared IBD between pairs of samples. During
my work other methods for long-range phasing and detecting of recent IBD were
released. In this chapter the newly described methods are evaluated.
The work presented here was described in a published article (Glodzik et al.,
2013).
Outline. We describe ANCHAP, a new long-range algorithm for detection of
identical by descent haplotypes in genetically isolated populations. Our method
is designed to detect borders of regions of identity by descent precisely, with min-
imal computation time and with state-of-art sensitivity and false discovery rates.
We compare ANCHAP against other long-range methods, a short-range method,




2.1.1 Properties of recent identity by descent
Expected lengths of haplotypes shared IBD can be derived by making assump-
tions about population history and properties of the recombination process. Hap-
lotypes that are identical by descent originate ’from a common ancestor without
either of them experiencing a recombination’ (Powell et al., 2010). The length of
a common haplotype between a pair of samples depends on the number of recom-
binations that occurred on the haplotypes since their common ancestor, so also
indirectly on the number of generations that carried the haplotype. Assuming
that genetic positions of cross-over events follow a Poisson arrival process at rate
1 per Morgan, we can derive the expected length of a shared haplotype and its
variance. For two individuals sharing a haplotype inherited from a common an-
cestor, the lengths of the shared regions are exponentially distributed with mean
equal to (2n)−1 Morgans, where n is number of generations back to most re-
cent common ancestor (MRCA) (Browning and Browning, 2010; Haldane, 1919).
However, the distribution of segment lengths has variance of (2n)−2 Morgans,
so the correspondence of segment length with time to common ancestor is only
approximate. For example, for a pair of individuals with a common ancestor 25
generations ago, the expected length of a shared haplotype segment is 2 cM, with
standard deviation of 2 cM.
Furthermore, we expect haplotype sharers from a population isolate to form
clusters. As shown in Figure 2.1, where several individuals co-inherited the same
haplotype IBD at a locus, they will all share IBD with each other. Haplotype
sharing with respect to the gametes of each individual is a transitive relationship.
If a haplotype A is IBD with haplotype B, B with C, then A is IBD with C.
These characteristics of IBD sharing are assumed in the algorithm for detecting








Figure 2.1: Haplotype sharing within a population isolate. Genotyped individuals
are identified by numbers 1 to 5. Each individual has two haplotypes, represented
by thick light-grey bars. Red, blue, and green dotted lines represent identity by
descent of two haplotypes in a genomic region. The dark-grey shaded haplotypes
are unique in the sample, and they are not shared between the sampled subjects.
2.1.2 Identifying regions of IBD sharing from SNP data
After the first long-range phasing algorithm was described by Kong et al., sub-
sequent ones appeared with implementations (Kong et al., 2008a, 2009). Hickey
at al. presented a method that was very similar to Kong’s in that it also de-
tected IBD in genetic regions that a genome is first divided into (Hickey et al.,
2011). Subsequently Systematic Long Range Phasing (SLRP) appeared, which is
a more flexible, elegant probabilistic model (Palin et al., 2011). As an alternative
to long-range phasing appeared, FastIBD, which uses a HMM-based short-range
method. The likely phasing errors are then corrected when identifying IBD shar-
ing between genotypes which were phased. The algorithms are described in more
detail in Chapter 1.
In this chapter for comparison we used SLRP and FastIBD, each represent-
ing long-range and short-range methods for detecting haplotypes shared IBD
between pairs of samples. SLRP exemplifies a long-range method capable of per-
forming probabilistic inference simultaneously for pairs of individuals, at likely
high computational cost. FastIBD reduces the computational effort by more con-
cise haplotype modelling. In contrast, the method I developed, ANCHAP, is a




In our study of ancestral haplotypes we analysed four European cohorts, three
of which (ORCADES, CROATIA-VIS, CROATIA-KORCULA) are from isolated
island populations and one from a mainland population (SOCCS).
The Orkney Complex Disease Study (ORCADES) is a family-based, cross-
sectional study in the isolated Scottish archipelago of Orkney (McQuillan et al.,
2008). Genetic diversity in this population is decreased compared to mainland
Scotland, consistent with the high levels of endogamy throughout history. Orkney
has been inhabited for over 5000 years, but the original population was almost
completely replaced by Norse Vikings about 800-900 CE. From about 1300 to
1600 CE there was an influx of mainland Scots (Wilson et al., 2001). For this
analysis we used data from 749 participants aged 18-100 years from ten islands,
however for the purposes of evaluation of methods we removed parents from
genotyped parent-offspring pairs which reduced the cohort size to 597 individuals.
Genotyping in the study was done using the Illumina HumanHap300 array with
302379 single nucleotide polymorphisms (SNPs) after quality control.
The CROATIA-VIS study is a family-based, cross-sectional study in the vil-
lages of Komiza and Vis on the isolated island of Vis that included 1,056 exami-
nees aged 18-93 years (Vitart et al., 2006). The CROATIA-VIS study genotyping
used the Illumina Hap300v1 SNP chip with 301069 SNPs after quality control.
The CROATIA-KORCULA study is a family-based, cross-sectional study in
the villages of Lumbarda, Zrnovo and Racisce on the isolated island of Kor-
cula in Croatia (Polasek et al., 2009). The study included 965 examinees aged
18-95 years. The CROATIA-KORCULA study genotyping used the Illumina
Hap370CNV SNP chip with 317223 SNPs.
The Study of Colorectal Cancer in Scotland (SOCCS) is a case-control study
of prospectively collected colorectal cancer cases from all Scottish hospitals, and
matched controls. One thousand participants in each group in the first phase of
the study were genotyped with Illumina HumanHap300 array with 306204 SNPs.
The participants for the control group were matched by age, sex and region to
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cases according to a nearly complete population based register, and then selected
at random. We analysed the genotypes from the control group, so as to obtain a
sample representative of the Scottish population as a whole.
2.2.2 Recent identity by descent in population isolates
In an isolated population such as the Orkney population, founded by Viking set-
tlement about 50 generations ago, and where population size has been constrained
over many generations, the time to MRCA is either of the order of 1000 genera-
tions ago, during the early settlement of Europe, or less than 50 generations ago.
To be able to use IBD sharing to infer sharing of rare variants, taking into ac-
count mutation rates (Duret, 2009; Nachman and Crowell, 2000), we restrict the
definition of IBD sharing to sharing via a recent common ancestor. In practice,
we can only do this by setting a minimum length for the shared region. For this
study we set the cut-off at 2 cM, equal to the expected length of sharing given
a time to MRCA of 25 generations. We used the high-resolution genetic map
from the HapMap project (Myers et al., 2005). Additionally, the cut-off at 2 cM
has been suggested in literature as a threshold above which accurate detection
from contemporary genotyping arrays can be obtained (Browning and Browning,
2010).
2.2.3 Algorithm of ANCHAP
The objective of ANCHAP is to infer recent identity by descent from SNP data
with maximum sensitivity and specificity, which means that it should declare IBD
only where the haplotype was co-inherited from a recent common ancestor, and
find all of such regions.
The algorithm consists of three stages:
1. Stage I. First scan for IBD sharing from comparisons of multi-locus geno-
types of all pairs of individuals.
2. Stage II. Splitting haplotype sharers by alignment and phasing. Individuals
carrying parts of the individual’s ”maternal” haplotype are distinguished
from ones that carry the ”paternal” haplotype. While the actual paternal or
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maternal origin of the proband’s haplotypes is unknown, haplotype sharers
are split into two groups.
3. Stage III. Second scan for haplotype sharing: a more sensitive and spe-
cific scan for IBD sharing, by pairwise comparisons of partially uncovered
haplotypes.
In Stage I, ANCHAP detects IBD sharing between pairs of multi-locus geno-
types, scanning for large regions without opposing homozygotes. Allelic dosages
at each SNP are coded as 0, 1 and 2, and opposing homozygotes between two
individuals at a SNP are when allelic dosages are 0 for first individual and 2 for
the second one, or 2 and 0. Where there are no opposing homozygotes over a
long region, a haplotype is likely to be shared IBD. To account for uncertain
sharing near the boundaries of a region with no opposing homozygotes, a number
of markers at the margins are trimmed, and are not included into the shared
region. The parameters of the method are the IBD threshold (the minimum ge-
netic length in centiMorgans of a region without opposing homozygotes between
a pair of genotypes) and the number of markers to be trimmed at margins. The
threshold values in centiMorgans relate to the time to common ancestor from
whom the haplotype was inherited, while values expressed as number of SNPs
exclude regions with low SNP density.
Stage II of the algorithm is executed for each proband in a study separately.
In a given region, in order to reconstruct phase, the proband’s haplotype sharers
can be split into two groups by alignment in Stage II. If sharers of proband’s
haplotypes on both gametes are present, they will form two groups. If sharers of
only one gamete are present, or if the proband is homozygous by descent they
will form one group. When sharers of each proband’s haplotypes are identified,
phasing becomes possible. We can recover the proband’s haplotypes at each locus
where at least one of the haplotype sharers is homozygous, but information about
all of the homozygotes among the sharers reduces the number of phasing errors.
Because a haplotype is shared, the haplotype sharer’s allele at a homozygous locus
must be the same as the allele on the proband’s haplotype (Kong et al., 2008a).
Each homozygous SNP among haplotype sharers is a ”vote” for consistent phase
at proband’s heterozygous locus; and votes from all homozygous sharers at a locus
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are added up to decide phase. As the method distinguishes groups of individuals
sharing each of the proband’s haplotypes in a region without recourse to pedigree,
the actual paternal or maternal origin of these proband’s haplotypes is not known.
Haplotype sharers are split into two groups, which could correspond to haplotype

















































Figure 2.2: Example of IBD detection (Stage I) and alignment of IBD regions
(Stage II) for one individual from ORCADES, chromosome 2. First we find
his/her haplotype sharers across the genome, and mark the regions of putative
IBD sharing as segments. The shared sequences are aligned into two groups, and
marked red, and blue accordingly. The grey segments denote misaligned shared
sequences. Individual 697 is a full sibling of the proband, with almost the entire
chromosome shared and more distant relatives share smaller blocks. Regions
of increased IBD are visible, which could arise in parts of genome where we
incorrectly infer time to common ancestors from whom haplotypes were inherited.
In Stage III of ANCHAP we make use of the phase information obtained from
IBD regions detected earlier. When partially complete haplotypes have been in-
ferred, a second scan for IBD sharing is undertaken, exploiting the additional
phase information gained. Phased haplotypes are compared between samples
and IBD is declared when they continuously match across a number of markers.
The idea for this second scan for haplotype sharing was inspired by the hidden
Markov model described in (Genovese et al., 2010). A pair of completely known
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haplotypes can have different alleles at any phased locus, while in a pair of un-
phased genotypes only at loci homozygous for both individuals are indicative of
sharing. Partially complete haplotypes carry more information for IBD detec-
tion, and thus the second scan can be more informative. To detect IBD from
comparisons of nearly complete haplotypes, we can use a smaller threshold in
terms of consecutive number of SNPs than the one that delineates IBD sharing
from IBS in Stage I, and we no longer need to trim the margins of the shared
regions as in Stage I. Recent IBD is declared in a region of consecutively matching
alleles between haplotypes that spans a sufficient genetic distance, and when the
number of phased markers in the region exceeds the threshold of minimum phase
information.
2.2.4 Settings required by ANCHAP
ANCHAP requires values for the following settings:
• TI - IBD threshold (Stage I). Minimum length of a region without opposing
homozygotes before it is declared as IBD, expressed in centiMorgans.
• RM - IBD region margins (Stage I). Number of markers trimmed from
margins of IBD segments.
• Alignment parameters: OT overlap threshold (number of heterozygous SNPs
where two segments overlap) and matching threshold MT (Stage II).
• PIII - minimum number of markers phased for both individuals in a putative
IBD region (Stage III).
• TIII - IBD threshold (Stage III), expressed in centiMorgans.
Using this notation for the parameters, algorithms for Stages I, II and III of
ANCHAP are described in Figures 2.3, 2.4, 2.5 and 2.6.
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Figure 2.3: Stage I: algorithm for first scan for sharing from unphased genotypes
Input: G, TI , RM
G : Genotype matrix: N×M (N : Number of samples, M number of SNPs),
with Gi,j ∈ {0, 1, 2,NA} - allele dosage
1. initialise IBD.segments (empty list for storing IBD segments)
2. for all pairs of individuals (i, j)
(a) identify segments of genome longer than TI centiMorgans without op-
posing homozygotes between multi-point genotypes of i and j,
(b) for all segments
i. trim RM from each margin of an IBD segment identified in (a)




Figure 2.4: Stage II: algorithm for alignment of IBD segments.
Input: G, IBD.segments, OT , MT
1. Initialise H1, H2 - two matrices to store phased haplotypes of all probands,
of same size as G. Initialise them at homozygous loci, otherwise leave
unknown.
i.e. H1(G == 0) = 0, H1(G == 1) = NA, H1(G == 2) = 1, similarly for
H2.
2. Initialise gam - a vector of same size as IBD.segments, gam ∈ {1, 2}, to
store which proband’s gamete a segment belongs to
3. for all individuals i
(a) IBD.segments.i - IBD segments of individual i with others, sorted by
the segment length in descending order
(b) for all segments s in IBD.segments.i
i. check if the genotype of the haplotype sharer in segment s is
matching haplotype 1, 2, or none of the proband i, with parame-
ters: if there are enough phased loci as specified by OT and that
i’s haplotype alleles agree with sharers genotype with tolerance
MT , accordingly assign 1 or 2 to gam[s]
ii. based on the new segment and its gamete assignment, update i’s
haplotypes in H1 and H2
(H1, H2) = phase(i, IBD.segments.i[1 : s], gam[1 :
s], G,H1, H2) (Figure 2.5)
Output: H1, H2, gam
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Figure 2.5: Stage II: algorithm for phasing using the aligned IBD segments
(H1, H2) = phase(i, IBD.segments.i, gam,G,H1, H2)
1. initialise vectors counting phase ”votes” , at each locus: ”votes” for ma-
jor allele on gamete 1 votes.H1.major, and for minor allele on gamete 1
votes.H1.minor
2. for all genetic loci l
(a) IBD.segments.i.l is a list IBD segments with individual i spanning
locus l
(b) identify all homozygotes of haplotype sharers at locus l from G
(c) according to the homozygous genotypes, and their gamete assignments,
update phase votes votes.H1.major and votes.H1.minor
(d) If votes.H1.major 6= votes.H1.minor, decide on phase at locus l ac-
cordingly, i.e. major H1 if votes.H1.major > votes.H1.minor
Output: updated H1, H2
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Figure 2.6: Stage III: algorithm for second scan for sharing from partially com-
plete haplotypes
Input: H1, H2, TIII , PIII
1. initialise IBD.segments.III(empty list for storing IBD segments)
2. for all pairs of individuals (i, j)
and 4 gamete combinations (g1, g2) ∈ {(1, 2), (1, 1), (2, 1), (2, 2)}
(a) identify segments of genome without opposing homozygotes between
multi-point haplotypes of i and j from gametes g1, g2, longer than
TIII centiMorgans, with at least PIII phased SNPs
(b) for all found segments
i. add indices of start and end SNPs, indices of individuals i, j, ga-
mete indicators g1, g2 to IBD.segments.III
Output: IBD.segments.III
2.2.5 Comparison of methods
We evaluated methods for detecting recent IBD using genetic data for parent-
offspring trios. We compared ANCHAP against SLRP - a fully probabilistic
method for long-range phasing, and against fastIBD - a short-range method
designed for populations of unrelated individuals. We evaluated their results
genome-wide against recent IBD that can be reliably detected by comparison of
haplotypes phased using parental genotypes.
Reference haplotype sharing was recovered between individuals whose parents
were also genotyped. Among the individuals genotyped in ORCADES, there were
58 individuals with both parents genotyped, and on average 80% of heterozy-
gous loci of such reference individuals were phased. We identified the regions of
reference recent IBD sharing between pairs of reference individuals where their
haplotypes are identical for at least 2 cM, over at least 100 SNPs. For genotyping
arrays used in this study 2 cM corresponds roughly to 200 SNPs, and setting a
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lower threshold eliminates only the regions with particularly low SNP density.
Such a definition of reference IBD segments carries possible problems. Firstly,
by setting a threshold on length of the segments, we are not setting a precise
cut-off for time to common ancestor. Given length of a haplotype shared IBD
there is much uncertainty about time to the common ancestor from which the
haplotype was inherited. This is further discussed in Chapter 5. Secondly, there
may be genotyping errors or incomplete phase in the genotypes of the parents,
and therefore the reference segments may be inaccurate. An alternative would be
to generate true IBD segments and genotype data through simulations, yet this
would involve making many assumptions about the history of the populations.
Our reference IBD segments from ORCADES should reflect the population well.
Each of the compared methods was applied to genotype data from the 597
individuals in ORCADES, free from parent-offspring pairs. The results between
the 58 reference individuals were evaluated against the regions of reference IBD
obtained from their known haplotypes, as also parents of the reference individuals
were genotyped. For fairness of the comparison with ANCHAP, segments shorter
than 2 cM had been pruned from results of SLRP and fastIBD. Before this simple
post-processing of the result, ANCHAP outperformed the other methods. Since
the aim is to recover regions of IBD sharing longer than 2 cM, I found this post-
processing fair.
The total number of markers in output regions that are also in the reference
IBD regions is TP (true positives), in reference regions but not in the output
regions is FN (false negatives), not in reference regions but in the output regions
is FP (false positives). For each method in the comparison we quote sensitivity
defined as the ratio TP/(TP + FN) and false discovery rate FP/(FP + TP ).
Parameter tuning for the methods was informed by the following performance
metrics:
• sensitivity - TP/(TP + FN),
• false discovery rate - FP/(FP + TP ). We used false discovery rate, rather
than false negative rate, because it is informative for further analysis of the
IBD relationship. It is useful to know that given recent IBD was detected
at a locus, how likely a recent haplotype is not shared.
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In case of ANCHAP, there are also evaluation measures that express the
quality of alignment in Stage II:
• Ir - inconsistency rate - how many of the alleles of haplotype sharers were
homozygotes not consistent with homozygotes of the majority of the hap-
lotype sharers, divided by the number of haplotype sharers.
• Pa - percentage of aligned sequences in the first stage of an algorithm. Out
of all detected IBD regions in the first round, what proportion of them were
aligned into one of the gametes.
2.2.6 Parameter tuning
All of the compared methods require setting different parameters. The methods
were tuned according to their sensitivity and false discovery rate on a subset
of the ORCADES data set from chromosome 2, using the reference individuals
phased in parent-offspring trios, as well as by success of alignment in Stage II (Ir
and Pa)
We attempted to set the IBD threshold at Stage I of ANCHAP (TI) such
that the length of falsely assumed IBD regions is reduced (false discovery rate)
while recovering as much of the true IBD regions as possible (sensitivity), and
thus the phase recovery that uses the IBD segments is most accurate and max-
imally spread. The margin sizes RM were set by comparison of margins of IBD
regions deduced from genotypes and the reference haplotypes. The setting of the
alignment parameters at Stage II aimed at increasing the ratio of the IBD seg-
ments aligned into haplotypes (Pa), and minimizing the inconsistencies between
them (Ir), which indicate alignment errors. At Stage III, the minimum number
of markers phased for both individuals in a putative IBD region (PIII) was set
using the reference haplotypes and the sensitivity and specificity values.
Also using the values of sensitivity and false discovery rate in data from chro-
mosome 2, we adjusted the parameters of SLRP and fastIBD. SLRP required
setting the expected length of IBD regions and expected regions of IBS but not




The data sets were pre-processed in PLINK (Purcell et al., 2007) to eliminate
low quality markers. We removed markers with call rate of less than 95%, out
of Hardy-Weinberg equilibrium (p < 0.001), or those with minor allele frequency
lower than 1%. We excluded individuals with more than 7% genotype markers
missing, and retained only the autosomal SNPs. After pre-processing, the follow-
ing numbers of samples remained: ORCADES (749 individuals, 302,379 SNPs
on 22 chromosomes), CROATIA-KORCULA (945 individuals; 317,223 autoso-
mal SNPs, including 295,574 ORCADES SNPs), CROATIA-VIS (991 individu-
als; 301,069 autosomal SNPs, including 291,857 ORCADES SNPs), SOCCS (958
individuals; 306,204 autosomal SNPs, including 294,703 ORCADES SNPs). We




2.3.1.1 Reference sharing in ORCADES study
The evaluation of the algorithms was possible thanks to parent-offspring pairs
genotyped in the ORCADES study. There are 58 individuals with both parents
genotyped, and at 80% of their heterozygous loci they could be phased using their
parents’ genotypes. There are 160 with at least one parent genotype and they
could be phased at 70% of heterozygous loci.
To obtain the reference IBD information, we extracted IBD regions between
the 58 reliably phased reference individuals. We required alleles with identical al-
leles in a region of haplotypes larger than 2 cM and containing at least 100 SNPs.
Such regions are highly likely to be IBD since they are based on haplotypes
reconstructed from parents’ data. The search for IBD regions is more specific
when comparing known haplotypes than when comparing genotypes, since the
former uses information at all markers, while the latter only at doubly homozy-
gous markers. The length of IBD regions between the reference individuals is
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shown in Figure 2.7a. Frequency of IBD sharing across the genome is shown
in Figure 2.7b. To verify if the regions of increased IBD sharing coincide with
unusual SNP densities in region with respect to physical and genetic maps, we
show these below.
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(a) Lengths of reference IBD segments in the reference data set for 58 individuals from
ORCADES. Most of the shared regions are only slightly larger than 2 cM, giving a
median of 5 cM.
(b) Distribution of IBD segments across the genome in the reference data set for 58
individuals. Regions of common IBD sharing could arise because of many false positive
detections in a region, for example in regions with poor SNP coverage, or where genetic
map does not allow to distinguish recent from ancient IBD sharing. Top: frequency
of IBD sharing at a genetic locus, averaged over samples in study. Middle: genetic
positions of SNPs. Bottom: physical positions of SNPs. We conclude that there are is
no unusually low density of SNPs in the regions of frequent IBD. Around the peak on
chromosome 6 there are fewer recombinations than in neighbouring genetic regions.
Figure 2.7: Properties of IBD segments between the 58 reference samples in
ORCADES.
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2.3.1.2 IBD threshold in Stage I
In Stage I of ANCHAP we would like to phase all heterozygous genotypes with
maximum accuracy, and using this principle we set a parameter value for TI .
Genotypes would be widely phased if many haplotype sharers are detected through-
out the genome. There would be few phasing errors if there is no falsely detected
IBD sharing. Therefore the sensitivity and false discovery rate of detecting IBD
sharing, as evaluated on the reference phased individuals, are meaningful metrics
which will reflect the quality of phasing. The plot of sensitivity and false discov-
ery rates of IBD sharing for different IBD thresholds in Stage I is shown in Figure
2.8. In further experiments we set the threshold TI to 3 cM.
On the other hand, incorrectly detected IBD in the first stage does not neces-
sarily lead to phasing errors. When there is more than one haplotype sharer, and
some falsely detected IBD segments in the region, the alignment stage of AN-
CHAP will likely eliminate it if true IBD sharers are in majority. This is because
the phase of a genotype is decided by voting from genotypes of haplotype sharers
(see Figure 2.5).
































Figure 2.8: Sensitivity and false positive rate of IBD regions as recovered by
Stage I of ANCHAP. The numbers in green on the plot are the TI threshold
values expressed in centiMorgans.
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2.3.1.3 IBD region margins
At each margin of a putative IBD sharing region we trimmed RM = 100 markers.
In the experiments with the reference data, after cutting off 100 markers at each
side, 94% of detected sharing regions did extend to where the reference haplotypes
were no longer identical.
2.3.1.4 Stage II - alignment parameters
In Stage II of ANCHAP haplotype sharers are split into two groups based match
between sharers’ genotypes and haplotypes of a proband being reconstructed.
The algorithm starts with the longest and therefore most certain IBD regions
shared with other individuals, reconstructs a draft of the phase for genotypes of
an individual, and then matches the remaining sharers against the preliminarily
phased genotypes. Errors may occur in the preliminarily reconstructed haplo-
types, and therefore a few inconsistencies between the draft of the haplotypes
and the aligned sequences may be allowed.
There are two parameters necessary for this part of the algorithm. The overlap
threshold (OT ) specifies the minimal number of markers of overlap between the
draft of phase of an individual and the new IBD region shared. The matching
threshold (MT ) specifies how many alleles may be mismatching between the draft
of the phase and a genotype of the putative IBD sharer.
Appropriate values of parameters will result in more accurate splits of haplo-
type sharers into two groups and consequently in lower phasing error, and higher
proportions of genotypes will be phased. A higher proportion of the putative
IBD sequences would be therefore aligned (Pa). The genotypes of IBD sharers
who are all classified as sharing the same haplotype, should also be consistent be-
tween each other. There should be no opposing homozygotes between genotypes
of haplotype sharers of an individual, and therefore the inconsistency rate (Ir)
should be lower.
In Figure 2.9 we evaluate the impact of different values of the overlap threshold
and the matching threshold. For each pair of values, we evaluate the percentage
of the putative IBD regions successfully aligned (Pa), and the inconsistency ratio
(Ir).
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Figure 2.9: Experiments with parameters for Stage II of ANCHAP.
On the left Y-axis is Pa - percentage of aligned sequences in the Stage II of an
algorithm. On the right Y-axis is Ir - the inconsistency rate as a consequence of
alignment - how many of the alleles of haplotype sharers were homozygotes not
consistent with homozygotes of the majority of the haplotype sharers, divided by
the number of haplotype sharers.
Intending to maximise Pa while minimising Ir, in further experiments we chose
parameter values indicated by the vertical line.
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2.3.1.5 Stage III parameters
For an individual, where regions of IBD sharing were detected in Stage I and hap-
lotype sharers were assigned accordingly to gamete of origin in Stage II, his hap-
lotypes would have been partially recovered. In Stage III the algorithm searches
for haplotypes matching continuously in regions which are at least 2 cM long. In
addition we require that both of the compared haplotypes are phased. Another
parameter (PIII) specifies a minimum number of markers phased in both of the
haplotypes. The default parameter value is 200 SNPs.
In Table 2.1 we show the accuracy of IBD detection when the PIII threshold is
varied. With values of the parameter below 100 SNPs sensitivity is not increased,
as there are hardly any reference IBD segments with fewer than 100 consecutive
and phased SNPs. For larger values of the threshold false discovery rate decreases,
because they eliminate regions with low SNP density or unphased genotypes. In
order to reduce false discovery rate, in further experiments we set PIII to 200
phased markers.






Table 2.1: Experiments with values of the parameter for Stage III - PIII . This
parameter specifies how many markers in the region of putative IBD need to be
phased in the relevant region of two multi-point genotypes. Below 200 markers
noted is increase of false discovery rate. Marked in grey is the value of the
parameter used in further experiments.
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2.3.2 Tuning settings of SLRP
Table 2.2 shows experiments with empirical and default parameter values for
SLRP. We compared accuracy of the algorithm in detecting the IBD segments on
chromosome 2 when used with the default values and with values obtained em-
pirically. The expected IBD length in centiMorgans was computed from the IBD
regions between the reference individuals in ORCADES, after they were phased.
The expected IBS but not IBD was calculated from IBS segments between the
reference individuals. Because we defined IBD as matching of haplotypes within
a region longer than 2 cM, out of the output of SLRP we filtered out the results
shorter than this threshold. Table 2.2 shows accuracy of SLRP.
SLRP setting ExpectedIBS ExpectedIBD sensitivity false
(cM) (cM) discovery rate
default 1 10 0.76 0.0076
empirical 0.42 9.17 0.77 0.0106
Table 2.2: Tuning parameter settings for SLRP. Only counting the IBD regions
longer than 2 cM. Sharing between the 58 Orkney individuals was evaluated using
data from chromosome 2. Marked in grey is the value of the parameter used for
a genome-wide comparison.
2.3.3 Tuning settings of fastIBD
In Table 2.3 we show experiments varying the scale parameter required by fastIBD.
The scale parameter controls the complexity of haplotype model created. We fil-
tered out regions shorter than 2 cM, in accordance with our definition of IBD.
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scale sensitivity false discovery rate













maximum advised 4 0.870 0.045
merge 10 runs 3 0.868 0.044
Table 2.3: Tuning parameter settings for fastIBD, using data from chromosome 2
for the 58 reference individuals from ORCADES. Marked in grey is the value of the
parameter used, where sensitivity matches that one of ANCHAP on chromosome
2.
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2.3.4 Phase propagation in ANCHAP
Table 2.4 shows the gain in sensitivity and the reduction in false discovery rate in
detection of recent IBD regions that are obtained at Stage III of our algorithm,
as compared to Stage I. On chromosome 2, sensitivity of IBD detection between
the 58 reference individuals per pair of individuals per marker grew from 0.75 to
0.81 in the second round. Detection of identity by descent for partially phased
haplotypes in the second round helped to reduce the false discovery rate from
0.16 to 0.01.
method ANCHAP Stage ANCHAP Stage III
sensitivity 0.75 0.81
false discovery rate 0.16 0.01
Table 2.4: Experiments with data from chromosome 2, 597 ORCADES individ-
uals with their genotyped parents removed. The identified regions of IBD were
evaluated against phased haplotypes of 58 individuals who could be phased using
the genotypes of their parents.
Stage III of ANCHAP offers better accuracy in detecting regions of IBD than the
first one.
2.3.5 Comparison of ANCHAP against other methods
Table 2.5 compares different tuning settings of ANCHAP, SLRP and fastIBD. Us-
ing data from chromosome 2, we manipulated parameters of SLRP and fastIBD
to match sensitivity and false discovery rate of ANCHAP. Notably, as the sen-
sitivity of fastIBD grows to exceed ANCHAP’s 0.81, the false discovery rate of
fastIBD reaches 0.024.
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method parameters and values sensitivity false discovery rate
ANCHAP TI - IBD threshold Stage I: 3 cM 0.81 0.010
TIII - IBD threshold Stage III: 2 cM
OT - overlap threshold: 10 markers
MT - mismatch tolerance: 2 %
PIII - minimum phase information: 200 SNPs
SLRP default 0.76 0.008
ExpectedIBS: 1cM
ExpectedIBD: 10 cM
SLRP empirical 0.77 0.011
ExpectedIBS: 0.42 cM
ExpectedIBD: 9.17 cM
fastIBD scale: 1 0.27 0.000
fastIBD scale: 2.8 0.80 0.021
fastIBD scale: 2.9 0.81 0.024
fastIBD scale: 3 0.83 0.024
fastIBD scale: 4 0.87 0.044
Table 2.5: Parameter tuning of ANCHAP, SLRP and fastIBD. Experiments with
data from chromosome 2, 597 ORCADES individuals with their genotyped par-
ents removed. The identified regions of IBD were evaluated against phased haplo-
types of 58 individuals who could be phased using the genotypes of their parents.
Highlighted rows indicate parameters used in genome-wide analysis.
Table 2.6 shows the accuracy of IBD detection of ANCHAP against the other
methods and their running times. Genome-wide, the methods achieved similar
sensitivity of IBD: from 0.75 for SLRP, 0.78 for ANCHAP and 0.82 for fastIBD.
Long-range methods, ANCHAP and SLRP resulted in similar false discovery
rates of 0.009 and 0.007 respectively, while for fastIBD it is 0.025. Genome-wide
inference of IBD with the SLRP model took much longer than for the other
methods: the analysis with SLRP took 207 hours, whereas ANCHAP handled
the same task in 20 hours and fastIBD in 12 hours.
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method ANCHAP SLRP fastIBD
sensitivity 0.78 0.75 0.82
false discovery rate 0.009 0.007 0.025
runtime(hours) 20 207 12
Table 2.6: Comparison of accuracies of methods for IBD detection. ANCHAP is
compared to SLRP - a probabilistic method for phasing in isolated populations,
and to fastIBD - a method designed for general populations. This genome-wide
comparison was run on the subset of 597 individuals from ORCADES, such that
their parents were not included. Regions of IBD were also evaluated using parent-
offspring trios. Experiments were run on a computer with a 2.0 GHz and 16 GB
of RAM.
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Additionally, in Figure 2.10 we show frequency of IBD sharing across the
genome, as detected by different methods. In Figure 2.11 compared are lengths
of IBD segments detected by different methods. As can be seen from the graph,
ANCHAP does not detect the longest segments of IBD sharing in one piece. This
could be because ANCHAP does not account for possible phasing errors in Stage
III.
Figure 2.10: Genome-wide view of haplotype sharing as recovered by the com-
pared methods. SLRP and fastIBD are more conservative in IBD detection, and
have less apparent IBD peaks.
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Figure 2.11: Lengths of detected IBD segments [cM]. IBD regions detected by
ANCHAP are generally shorter than ones identified by fastIBD or SLRP.
2.3.6 Sharing in different cohorts and across the genome
The average number of haplotype sharers per SNP varied from 9.4 in CROATIA-
KORCULA, through 12.3 in ORCADES and 12.6 in CROATIA-VIS. In SOCCS
which consists of genotypes of nominally unrelated individuals, there were only
0.9 sharers per locus on average.
The frequency of haplotype sharing varies not only between the cohorts, but
also across the genome. Figure 2.12 shows average counts of haplotype sharers
in different locations across the genome. Drops at the telomeres can be consis-
tently observed, as well as the peaks on chromosomes 2, 6, 8, and 9. In SOCCS
particularly notable are the peaks on chromosomes 2 and 6, that also occur in
ORCADES and CROATIA-VIS but not in CROATIA-KORCULA.
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Figure 2.12: Density of haplotype sharers across the genome, in the four cohorts.
The horizontal axis shows index of a SNP, and not its physical or genetic location.
Genetic positions of the peaks highlighted with diamonds are given in Tables 2.7,
2.8, 2.9, 2.10.
2.3.7 Regions of increased frequency of IBD
In Figure 2.12 marked with dots at horizontal axes are regions where recent IBD
is particularly common. Tables 2.7, 2.8, 2.9, 2.10 list positions of these peaks in
the genome. Next to the locations of peaks, shown are references to studies where
the same peaks have been found in different outbred and inbred populations, and




position position studies reporting differential
selection in region
interpretation
left [kb] right [kb]
2 134144 138947 Moskvina, Han Immunity (AMSD), lactase
(LCT)
3 15484 24365
6 27145 33161 Moskvina, McEvoy, Albrecht-
sen, Han
HLA region - immunity, zinc
fingers
8 95306 97626 Albrechtsen, Han COH1, VPS13B, COX6C
10 100639 119196
14 77965 88690 Albrechtsen
19 18379 34464
Table 2.7: Positions of peaks in frequency of IBD in ORCADES (build 36)
chromo-
some
position position studies reporting differential
selection in region
interpretation
left [kb] right [kb]
1 186888 190805 Han RGS1
2 47152 59773 Albrechtsen
6 25952 33936 Moskvina, McEvoy, Albrecht-
sen, Han




Table 2.8: Positions of peaks in frequency of IBD in CROATIA-VIS (build 36)
chromo-
some
position position studies reporting differential
selection in region
interpretation
left [kb] right [kb]
1 90094 101013





Table 2.9: Positions of peaks in frequency of IBD in CROATIA-KORCULA (build 36)
chromo-
some
position position studies reporting differential
selection in region
interpretation
left [kb] right [kb]
2 134028 139092 Moskvina, Han Immunity (AMSD), lactase
(LCT)
6 25535 33096 Moskvina, McEvoy, Albrecht-
sen, Han
HLA region - immunity, zinc
fingers
Table 2.10: Positions of peaks in frequency of IBD in SOCCS (build 36)
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Figure 2.13: Frequency of IBD sharing throughout the genome, when lengths of
IBD segments were expressed as a number of SNPs.
ORCADES - red, CROATIA-VIS - blue, CROATIA-KORCULA - green, SOCCS
- orange.
IBD peaks on chromosomes 6 and 11 had been apparent before a genetic map
was used for measuring length of IBD segments, and indirectly measuring time
to common ancestor from whom a haplotype was co-inherited.
Figure 2.13 shows peaks on chromosomes 6 and 11, which we removed by
specifying IBD thresholds as minimum length in centiMorgans, rather than as
minimum number of SNPs in a region. In Figure 2.13 the peak on chromosome
6 falls in the HLA region, where according to the genetic map recombinations
are infrequent, but the density of SNPs per centiMorgan is unusually high. The
shared haplotypes recovered around the peaks were probably co-inherited from
common ancestors in very remote past. The more ancient the common ancestor,
the more contemporary lineages there that carry the haplotype, which would
explain the peaks of IBD frequencies. As using the genetic map eliminates the
drastically high peaks, we believe that time to common ancestors of haplotype




In the previous sections we described ANCHAP - a new heuristic-based algorithm
for detecting recent IBD sharing from SNP data. The algorithm was compared
against SLRP - a probabilistic long range-phasing method and fastIBD - a short-
range program designed for studies containing nominally unrelated individuals.
We found that ANCHAP is an order of magnitude faster than SLRP and has
lower false discovery rate than fastIBD. We studied recent IBD in three isolated
populations and in a study of nominally unrelated individuals. We noted that in
some parts of the genome IBD sharing is particularly frequent.
2.4.1 Comparison with other methods for IBD detection
Design of the algorithms affects the performance of the methods for IBD in-
ference. Systematic Long Range Phasing (SLRP) is a model-based probabilistic
approach for simultaneous IBD detection and phasing. It can simultaneously han-
dle genotyping errors and phase uncertainty, yet this comes at the price of high
computational demand. The loopy belief propagation algorithm, which SLRP
uses for inference, may not find the optimal solution and is not guaranteed to
converge. ANCHAP does not explicitly model genotyping errors; phasing and
IBD detection are separate steps, yet in our test detects recent IBD as well as
the computationally more expensive SLRP. When a genotyping error gives rise
to a pair of opposing homozygotes in a region of IBD sharing, the region of shar-
ing detected by ANCHAP may be shorter, or missed altogether. However, in
ORCADES we encountered on average only 1 opposing homozygote per 10,000
markers in genotypes of parent-offspring pairs, so genotyping errors will not pre-
vent most of the shared regions from being detected. FastIBD is a method for
IBD detection designed for general populations (Browning and Browning, 2011a).
It builds a model of haplotypes which can capture only short range allele corre-
lations. This deficiency is then ameliorated by sampling multiple haplotypes for
each individual, and checking overlap of such samples between pairs of individ-
uals. FastIBD was more sensitive than ANCHAP or SLRP, but also returned
more false discoveries. A possible explanation for why fastIBD yields more false
discoveries is that haplotype re-sampling of short blocks may occasionally yield
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haplotype matches between samples by chance.
It seems unlikely that the differences in sensitivity and false discovery rate
between the methods would seriously affect the uses of detected IBD region in
mapping complex traits or IBD-based imputations. Sensitivity approaching 100%
would be desirable for downstream applications (Browning and Browning, 2011b),
but none of the methods achieves sensitivity of IBD detection of more than 81%
for the ORCADES data. In case of ANCHAP this probably results from inabil-
ity to handle the incorrect assignments in Stages I and II, which trigger phasing
errors, so that IBD is no longer detected in Stage III. Ability to recover from
sporadic phasing errors would certainly improve the sensitivity of IBD detection.
For SLRP incomplete IBD detection could be due to limitations of the inference
algorithm, conservative approach to declaring IBD, or low tolerance to inconsis-
tencies between the IBD sharing relationship and possibly noisy data. In case of
fastIBD, if for a pair of individuals sharing IBD there are few haplotypes which
would explain the genotypes, the program may not sample the matching pair. In
accordance with this observation, the highest sensitivity we could achieve was by
runs of fastIBD with scale parameter set to 4.0, repeated ten times. Together
with the sensitivity going up to 89%, the false discovery rate also grew to 7%.
When comparing the design of the algorithms, SLRP seems more elegant and
flexible than ANCHAP. The SLRP algorithm not only handles genotyping er-
rors, but also discovers IBD regions and haplotyping simultaneously. However,
inference on the Bayesian network in SLRP is computationally very expensive,
and its implementation relies on simplifications that likely impede performance
of SLRP. ANCHAP, on the contrary, has the advantage of simplicity in imple-
mentations which, according to the results of the experiments, does not impair
the performance.
The comparison of methods as well as parameter tuning are based on presence
of parent-offspring trios among the ORCADES samples. Genomic locations of
endpoints of reference sharing regions as determined by parent-offspring phasing
are only as accurate as the SNP density allows. The reference regions may still
have false endpoints because a recombination may not be detectable from SNP
alleles. However, the endpoints should not affect the results of the comparison, as
they will be small compared to the regions themselves; long matching haplotypes
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that do not descent from a common ancestor are unlikely. In the absence of
parent-offspring trios, several types of inconsistencies between the genotype data
and IBD relationships recovered could indicate errors. For example, the multi-
point genotypes of haplotype sharers, which are recognized to carry one of the
probands haplotypes, cannot have opposing homozygotes with respect to not just
the proband, but also each other.
2.4.2 Genetic maps and peaks of IBD
ANCHAP requires setting a minimum length of a segment between two multi-
point genotypes without opposing homozygotes, and above this threshold the
algorithm infers that two samples share a haplotype IBD. The threshold is ex-
pressed in centiMorgans, with respect to a genetic map (Consortium, 2007; Myers
et al., 2005). By expressing the threshold on a haplotype segment shared IBD in
centiMorgans, we indirectly limit the times to common ancestors from whom the
haplotypes were co-inherited. Such a correction is evident in the SOCCS data,
where using the HapMap genetic map markedly reduces the size of the peaks for
apparent IBD sharing on chromosomes 6 and 11, as shown in Figure 2.13.
Still, the genetic map may not fully account for population history, for example
the extent of linkage disequilibrium in DNA of isolate founders in different parts
of the genome, or selection pressure that favoured some variants in relevant parts
of the genome. In regions of extended linkage disequilibrium haplotypes may be
very similar to each other, which may be confusing for ANCHAP. If haplotypes
are very similar to each other, and we observe only unphased SNP genotypes,
our method may declare IBD incorrectly even when two individuals do not share
a recent common ancestor and their full sequences are not identical. If selection
acted on some part of the genome, it might have increased frequencies of some
haplotypes. ANCHAP would detect the selection signature as increased frequency
of IBD sharing in a region. Because of selection, times to common ancestors from
whom the haplotypes were inherited would date further back than elsewhere in
the genome. This gives rise to regions of increased frequency of IBD sharing.
Even when using the genetic map, we can observe regions of excess IBD
sharing also in SOCCS, a cohort composed mainly of unrelated individuals from
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across Scotland, around the two peaks on chromosome 2 and 6. These peaks also
occur in ORCADES and partially in the Croatian cohorts. Any two individuals in
SOCCS are likely to have only very remote common ancestors. Because selection
pressure or high linkage disequilibrium in the peak regions are not taken into
account, ANCHAP confuses the ancient common ancestors with more recent
ones.
We thus believe that while in general by using the genetic map we limit the
inference of IBD to segments with recent common ancestors from whom haplo-
types were co-inherited, in some parts of the genome we may not account for
extensive linkage disequilibrium among isolate founders or selection events.
2.4.3 Identity by descent and positive selection
Albrechtsen et al. have shown in simulations that positive selection gives rise
to excess IBD sharing (Albrechtsen et al., 2010). They also detect where recent
positive selection might have acted in the 11 populations from HapMap. They
find peaks on chromosome 6 in the HLA region and on chromosome 8, which
contains the defensin gene.
A new method for IBD detection based on a hidden Markov model is described
(Han and Abney, 2012). The model gives probabilities of all 9 IBD states between
pairs. The model is employed in a search for positive selection in genotype samples
from Kenya. A simulation study estimates the accuracy of the method. The
authors quantify IBD rates across the genome, and exclude the possibility that
the peaks are a reflection of increased linkage disequilibrium. In the increased
regions, they search for evidence for positive selection in literature. Around 50
signals were found, half of which are novel. Only the literature search is presented
as validation of the results, and no evaluation of significance is provided. They
also find peaks in the HLA region, and one on chromosome 11 which contains
clusters of olfactory receptors.
The HLA region is known for extensive conservation of haplotypes spanning
it (Ferreira et al., 2012). HLA molecules are expressed on many human cells,
and more than 100 SNPs in the HLA region have been implicated in autoimmune
and inflammatory conditions. Many of the described associations are with hap-
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lotypes, as otherwise the mapping efforts have been thwarted by the high linkage
disequilibrium.
2.4.4 Detection of positive selection through allele fre-
quencies
Genes under positive selection would reveal themselves through excess IBD, but as
a consequence also through altered allele frequencies. If several haplotypes carry
a variant under selections in a population, this would affect the allele frequencies
in the region. Moskovina et al. (Moskvina et al., 2010) analyse differences in allele
frequencies between participants of a schizophrenia study from Bulgaria, Ireland,
Scotland, Sweden and Portugal. They detect SNPs where allele frequencies are
significantly different in the populations. They list 11 top regions and annotate
them with gene ontology software.
Equivalently, traces of natural selection can be seen by computing Wright’s
fixation index FST (McEvoy et al., 2009). They identify 11 peak regions, annotate
them with genes they contain, and provide interpretation. Furthermore, they
demonstrate haplotype analysis of the HLA peak. They demonstrate a commonly
shared haplotype longer than 3 cM.
2.4.5 Possible improvements to the algorithm
To use ANCHAP in new studies, the the program would benefit from improve-
ments like explicit handling of genotyping errors and parallel execution.
2.4.5.1 Explicit handling of genotyping errors
At the moment the genotyping errors in array data are not explicitly accounted
for. I estimated in data from ORCADES that opposing homozygotes due to
genotyping errors occur only once per 10,000 SNPs. Because of the heuristics used
and the amount of data, the genotyping errors should be irrelevant. In the first
Stage of the algorithm, the inference relies on presence of opposing homozygotes,
which are unlikely to occur by chance. At Stage II, phase is decided based on
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genotypes of multiple sharers, most of whom are likely to be correct. Any single
genotyping error is unlikely to affect the haplotypes being phased.
However, explicit modelling of genotyping errors will be important for detec-
tion of IBD segments from next-generation sequencing data. In next-generation
sequencing data, SNP calls carry uncertainty depending on read depth. Handling
of genotype errors could be achieved through introducing hidden Markov models,
where hidden states correspond to whether a haplotype is shared, and observed
variables are possibly noisy genotypes.
2.4.5.2 Implementation
The algorithm has been implementing as an R package, for ease of prototyping
and sharing. String matching at Stages I and III was implemented in C++
for efficiency. Further improvement would be achieved if more of the code was
translated into C++, for example whole of Stage II.
While for cohorts with 1000 samples the running times are less than one day
on a compute cluster, running it on sets with 10000 individuals requires running
several smaller jobs in parallel. This can be achieved by dividing the genome
into chromosomes, as processing of chromosomes is independent. Furthermore,
in Stage II all individuals are processed independently of one another, so these
computing jobs could be run in parallel.
2.4.6 Conclusions
We have described methods for detecting regions of haplotypes shared IBD from
SNP data. We now proceed to applications of inferred IBD regions: optimisation





studies in population isolates
based on identity by descent
3.1 Background
The aim of resequencing studies in population isolates is to identify effects of
variants which outside of an isolate could be very rare. While cost of next gen-
eration sequencing is still significant, we can reduce costs of resequencing by
exploiting widespread identity by descent between the subjects. The reduction
of cost can be obtained by sequencing a subset of individuals whose haplotypes
are representative of study, and using identity by descent to impute genotypes for
non-sequenced samples. Imputations that rely on identity by descent (IBD) are
now recognized to increase the power of sequencing studies in population isolates
(Zeggini, 2011).
The aim of this chapter is to assess whether recent identity by descent dis-
covered in array data can be useful for optimising resequencing studies. This
could be achieved by optimal selection of individuals for resequencing, as well as
by more accurate imputations. We investigate accuracy of regions of identity by
descent inferred by ANCHAP, which has implications for imputations and the
algorithm of ANCHAP. Later we describe an algorithm for optimising the design
56
of resequencing studies in isolated populations. Finally, we discuss the design of
an algorithm for imputations informed by identity by descent.
3.1.1 Methods for optimisation of resequencing studies
Imputation models can be categorised into short and long-range ones, with the
former relying on linkage disequilibrium and the latter on longer regions of recent
identity by descent between samples.
3.1.1.1 Short-range imputation methods
Most short-range imputation methods use hidden Markov models (HMMs). HMMs
represent genotypes as mosaics of haplotypes from remaining individuals. The
visible states correspond to genotype data, and the hidden states correspond to
a haplotype mosaic. The models typically require parameters that represent re-
combination and mutation rates, and rely on haplotype blocks of 10-100 kb (Daly
et al., 2001). Where there are also longer, more recent IBD segments between
samples, short-range programs will not necessarily make use of them, because
they do not prioritise using longest haplotype segments as templates. In con-
trast, long-range methods use recent IBD segments, however they will not work
at all where there is no recent IBD.
Three examples of short-range imputation methods are IMPUTE2 (Howie
et al., 2009), MACH (Li et al., 2010) and Beagle (Browning and Browning, 2007).
MACH represents haplotypes in study samples as a mosaic of reference haplo-
types from the imputation reference panel only, for example HapMap haplotypes
(Gibbs et al., 2003). MACH first creates a haplotype mosaic for a subject us-
ing SNPs typed in both study and reference samples, and accordingly imputes
the genotypes not typed in study samples. In contrast, IMPUTE2 uses also
haplotypes from other study samples in addition to the reference haplotypes. In
IMPUTE2 the sampled mosaics are used for phasing only at SNPs typed for both
study and reference samples, and haplotypes at these universally typed SNPs are
then compared with reference haplotypes, assuming the phasing to be correct.
In addition to reference haplotypes, IMPUTE2 also allows use of unphased geno-
type reference samples. Beagle uses a similar imputation procedure, however it
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employs a more parsimonious model of haplotypes. All of the short-range imputa-
tion programs first perform phasing at universally typed SNPs, and subsequently
use the haplotypes for imputations.
3.1.1.2 Long-range imputation methods
Imputations could exploit long-range identity by descent, rather than using only
short co-inherited haplotypes. Where recent IBD is found, such imputations
could be more accurate, particularly for recent mutations, which create rare vari-
ants. No algorithm has been described which would use IBD to perform sequence
imputations.
IMPUTE2 does use the analogous concept of ’surrogate family’, however not
to find segments of IBD, but rather to speed up the algorithm. For a proband,
its ’surrogate family’ consists of samples most similar to proband’s genotype and
haplotypes, in terms of Hamming distance in the region considered (Howie et al.,
2011). In phasing, focusing on ’surrogate family’ members reduces the number of
hidden states of the hidden Markov models. For imputation, only haplotypes of
’surrogate family’ members are used from the reference samples. As each sample
is imputed using his custom set of reference samples, this allows using very large
reference sets. Because of the approximation IMPUTE2 may often make use of
long identical-by-descent haplotypes, but this is not explicit or guaranteed.
3.1.1.3 Optimisation of resequencing studies using recent IBD
Optimisation of resequencing studies was demonstrated in an extremely isolated
population of the Pacific island Kosrea in Micronesia (Gusev et al., 2012). They
proposed both an algorithm for choosing samples from resequencing, and a way
to evaluate regions of IBD inferred from array data against sequence data. In the
pilot study, they chose the seven sequencing samples, according to SNP genotypes
previously available. The selection of individuals is driven by their algorithm
called INFOSTIP, which exploits presence of IBD segments between individuals
in a study. It is a greedy algorithm for optimising resequencing studies, which is
described here in detail before I describe my modifications.
In INFOSTIP (Gusev et al., 2012), the choice of next individual for sequencing
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is driven by its utility given the previously selected individuals. Let:
• P be the set of individuals in a population,
• Q - the subset of individuals already sequenced,
• i - index of an individual,
• k - a locus in the genome,
• R(i, q) - set of IBD segments between individuals i and q,
• G - the set of SNPs in genome.
Chosen for resequencing each time is an individual that maximises the util-
ity of sequencing given Q, U(i, Q). The utility is defined with respect to total
information content (TIC) of set {Q, i} about the whole population P , and by
information content of the set Q about P .
U(i, Q) = TIC(P, {Q, i})− TIC(P, {Q}) (3.1)
Total information content expresses how much information about genotypes
of total cohort with individuals P is known if individuals in Q are sequenced,
however it is not a measure coming from the field of information theory. Rather,
it is fraction of all SNP genotypes in data for P that would be known through
either sequencing individuals in Q or ones that could be imputed from Q to P ,
and the number of all SNP genotypes in P . The number of SNP genotypes that





For an individual i not in Q, the amount of information that can be imputed is
obtained by summing over genetic loci. This uses an indicator whether a genotype
of individual i can be imputed at locus g from sequenced samples in Q.
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L(i, Q) = Σg∈GI(i, g, Q) (3.3)
Lastly, the indicator is defined with respect to the IBD segments R. A geno-
type can be imputed for individual i at locus k if there exists (∃) an individual
q, such that i and q share IBD in a region containing k.
I(i, k,Q) =
{
1 ∃q ∈ Q(∃(l, r) ∈ R(i, q)(l < k ∧ r > k))
0 otherwise
(3.4)
Therefore, when selecting a new individual, the algorithm considers all regions
of genotypes where they share IBD with sequenced sample, as known. In practice,
they would be only known when there is a haplotype sharer for both gametes of
a proband, and the genotypes of a sequenced samples are homozygous, through
a similar argument like for long-range phasing algorithms in Chapter 2.
The algorithm chooses individual i that maximises U(i, Q), and adds i to
Q. This is a greedy procedure, which is a necessary approximation given that
in general the maximal coverage problem is NP-hard. An important part of
INFOSTIP is the data structure for storing IBD regions, such that they can be
efficiently queried for locations.
The algorithm was evaluated through the quality of imputations at deliber-
ately concealed SNPs. The authors did not propose an IBD-based imputation al-
gorithm, but rather used Beagle, a short-range imputation method. It was shown
that random selection of individuals gave imputations of considerably lower qual-
ity of imputations than when prioritised according to INFOSTIP.
Furthermore, the authors also evaluated quality of IBD segments against the
whole sequence data for seven selected samples. For a pair of samples that are IBD
in a region, there should be no opposing homozygote genotypes in sequence data.
If a an individual carries two copies of a rare allele at SNP, and his haplotype
sharer carriers no copies of the rare alleles at the SNP, this is not consistent
with a haplotype being shared. The authors counted all opposing homozygotes
between pairs in regions previously inferred as identical by descent. They also
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counted all loci where such inconsistencies could have happened, namely where
both samples are homozygous at a SNP in a region that the two individuals
share IBD, and when at least one genotype has two copies of the rare allele. Let
I be the number of opposing homozygotes between pairs of IBD sequences and A
number of mutually homozygous genotypes between pairs of IBD sequences, with
at least one being non-reference allele. Concordance C is defined as the ratio of





Opposing homozygotes suggest incorrectly detected IBD or low quality of
sequence genotype calls. The authors of INFOSTIP take the concordance rate
as a measure of imputation accuracy when only one individual from the pair was
sequenced. By chance match of alleles, the concordance will not be zero even
at non-IBD segments, therefore a background concordance of sequence SNPs is
calculated for reference.
This method of optimising resequencing studies and evaluating IBD segments




Array data has been merged from ORCADES data set, obtained with a Illumina
Human Hap300 array with 293,687 SNPs, and from the Orcadian multiple scle-
rosis study, where a Omni1 array was used with around 1 million SNPs. After
merging and quality control, there were 171,755 genotypes for 908 individuals,
from which IBD segments were identified.
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3.2.2 Exome data
Individuals for exome sequencing were chosen from ones who had previously been
genotyped. The subset of individuals was selected to minimise relatedness be-
tween samples and maximise representation of haplotypes, using my algorithm
described later in this chapter.
Whole exome sequences were generated using the Agilent SureSelect All Exon
50 Mb kit. Average depth of reads was 29.5 x. Read alignment was done with
reference to human genome build 19, using Stampy (Lunter and Goodson, 2011).
GATKs genotyper generated genotype calls, using default parameters (McKenna
et al., 2010), and identified and 217,015 variants. Alignment of reads and SNP
calling were performed by Ross Fraser (Joshi et al., 2013).
The resulting genotypes underwent rigorous quality control, since in further
analysis we would like to assume their full correctness. Kept were only such
variants with phred-scaled quality of more than 40, called in at least 50% of
subjects, and with minor allele frequency more than 0.75%. Further criteria
included Hardy-Weinberg equilibrium test with p-value greater than < 10−4, and
mapping to homologous regions. After quality control, there were 100 samples
with 159594 SNPs. Retained were only the sites with quality exceeding 40, and
genotypes with quality at least 20. Available for analysis was exome sequence data
for 99 individuals from the ORCADES study, previously genotyped with GWAS
array. There were 7730 SNPs in common between the array and called exome
variants, which we used to assess the match between these two data types. We
excluded seven samples for whom the correlations between the exome and array
genotypes was less than 0.5, because we inferred that genotyping and sequencing
were done on different samples and the sample identities were misleading. For the
remaining 92 average correlation between exome and array genotypes was 0.92.
The imperfect match between array and sequencing genotypes could result from
errors in areas of lower sequencing depth. The resultant exome genotypes were
used for evaluating accuracy of inferred IBD segments.
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3.2.3 Evaluation of identity by descent established from
array data
Identity by descent inferred from array data should also hold for untyped loci in
the region. We can thus confirm postulated IBD-regions between two samples
using SNPs in exome sequence data. Even though the latter is unphased and
possibly noisy, absence or presence of opposing sequence homozygotes between
putative haplotype sharers can cast light on quality of the inferred IBD regions.
As a measure of consistency between sequence genotypes in the IBD segments
detected from array data we used concordance as defined in Section 3.1.1.3. This
enables comparisons with earlier work, and concordance also has the interpre-
tation as the probability of correct imputation from sequence of IBD sharers.
Finally, since the computation involves only pairs of genotypes where at least
one is homozygous on the non-reference allele, it is approximately independent
of allele frequencies.
The procedure of evaluating IBD regions with sequence data thus involves it-
erating over all IBD segments identified from array data, and counting opposing
homozygotes between sequences of the pairs. In this way we can see if the oppos-
ing sequence homozygotes occur more frequently in some regions of the genome,
whether they occur more often in tails of such segments, and whether the second
round of ANCHAP indeed improves the quality of IBD inference. The procedure
is described in Figure 3.1.
We repeated the procedure for control IBD segments. The control segments
are the same as the ones detected from data, but the identities of the individ-
uals from whom they come were randomly permuted. As long IBD between a
pair of random samples is unusual, such control segments are unlikely to be in
IBD regions, but have same lengths as the IBD segments detected. The control
segments allow as computing background concordance rates in non-IBD regions.
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Figure 3.1: Evaluation of IBD segments against exome SNPs: computing concor-
dance C
Input: E, IBD.segments
E: Exome SNP matrix: N ×M (number of samples by number of exome
SNPs), with Ei,j ∈ {0, 1, 2,NA} - allele dosage
IBD.segments = {(id1, id2, start.SNP, end.SNP)} (list of IBD segments
from array data, each with identities of sharers, and indices of start and
end SNPs)
1. initialise A := 0, I := 0
2. loop through IBD.segments
(a) access the pair of exome SNPs in E relevant to an IBD segment
(b) count opposing homozygotes between the pair of exome segments: ii
(c) count mutual homozygotes in the exome segments: ai
(d) update to summary variables: I := I + ii, A := A+ ai
3. C = A−I
A
(Calculate concordance of exome SNPs in IBD regions)
Output: C
3.2.4 Description of algorithm for selection of samples in
resequencing studies
The uncovered IBD sharing within a cohort can be used for efficient selection of
individuals to resequence, with a view to using them as a reference for imputation.
Selection of individuals for resequencing is based on maximizing representation
of haplotypes and minimizing multiple resequencing of the same haplotypes. As
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the first individual for resequencing we choose the one whose haplotypes have
the most copies in the rest of the cohort. After excluding regions that have been
covered by sharing with individuals already chosen, we repeat the procedure of
selecting the individual with most copies until a target level of coverage has been
achieved (Figure 3.2).
The algorithm is very similar to one described in (Gusev et al., 2012) - it is
also greedy and picks individuals for sequencing to maximise information content.
However, the algorithm presented here also takes into account parent-of-origin
of recent IBD. To consider a segment of unsequenced genotypes imputable, our
algorithm requires at least one sharer of each of the two haplotypes. We therefore
modify the total information content, by a factor of 2 to reflect that now we wish
to impute an allele on each of the two haplotypes of a proband:
TIC ′(P,Q) =




L′(i, Q) = Σg∈GI
′(i, g, Q). (3.7)
We also modify the indicator I ′ of whether a genotype is imputable to indicate
how many alleles of a proband can be inferred: 2, 1 or 0. To do so, we augment
the description of IBD segments. The sets of IBD segments of proband i with
individual q such that i and q share IBD on the first and second gametes are
denoted by R′1(i, q) and R
′
2(i, q). Both alleles can be imputed if there exist hap-
lotype sharers for both gametes (hence logical ’and’ denoted by ∧), one allele can
be imputed if there is a haplotype sharer of either gamete (hence logical exclusive
’or’ denoted by Y), 0 otherwise, as shown in Equation 3.8.
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I ′(i, k,Q) =

2 ∃q1 ∈ Q(∃(l, r) ∈ R′1(i, q)(l < k ∧ r > k))
∧∃q2 ∈ Q(∃(l, r) ∈ R′2(i, q)(l < k ∧ r > k))
1 ∃q1 ∈ Q(∃(l, r) ∈ R′1(i, q)(l < k ∧ r > k))
Y∃q2 ∈ Q(∃(l, r) ∈ R′2(i, q)(l < k ∧ r > k))
0 otherwise
(3.8)
My work on this algorithm had been completed before publication of (Gusev
et al., 2012), and we had not been aware of the competing algorithm.
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Figure 3.2: Choosing an optimal subset of individuals for re-sequencing
Input: IBD.segments, targetN
IBD.segments = {(id1, id2, start.SNP, end.SNP)} (list of IBD segments
from array data)
target.n - target number of individuals for resequencing
1. initialise I (matrix |P |×|G| for storing the indicator variables I if a genotype
is imputable)
2. initialise Q (empty set of individuals for resequencing)
3. for n ∈ 1 . . . target.n
(a) for i ∈ P \Q (for all non-selected individuals)
i. compute U ′(i, Q), based on IBD.segments and I, according to
Equation 3.1
(b) choose an individual i.picked = maxiU




3.3.1 IBD inferred from array data against the exome
SNPs
Between genotypes of the verified individuals, in Stage I ANCHAP found 33982
IBD segments, and 32868 in Stage III. At an average locus, a sequenced individual
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shared IBD with 0.8 other sequenced individuals. Between pairs of IBD sequences
from Stage I, there were 8430 homozygotes of opposing alleles in exome sequence
data, and 1922 in Stage III. Respective concordance (C) scores were 0.87 and 0.96.
The moderately low number of opposing homozygotes in sequence data in IBD
regions suggests that the inference of IBD regions is accurate, but because most
IBD sequences fall outside of the exons, no verification there is possible. However,
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(a) Concordance (C) of exome sequences in IBD segments of different length, when
length is expressed as number of array SNPs a segment contains. The longer a re-
gion, the higher the concordance. Irrespective of length, concordance in detected IBD
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(b) Concordance (C) of exome sequences in IBD segments of different length, when
length is expressed in centiMorgans.
Figure 3.3: Concordance (C) of exome sequences in IBD segments identified from
array data, depending on length of the segments.
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Figure 3.4: Genome-wide view of concordance (C) of exome sequences in IBD
segments identified from array data. Note that in regions where sharing IBD is
more frequent than elsewhere (chromosomes 2, 6), concordance is typical, within
one standard deviation from genome-wide mean and within standard deviation of
concordance computed for control segments. This implies that the IBD segments
recovered in these regions are not artefacts of the inference method.
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Figure 3.5: Concordance (C) of exome sequences in IBD segments identified from
array data, in Stages I and III of ANCHAP. Top: normalised position within
IBD segments. Bottom: position with respect to IBD segment borders. Control
IBD segments generally give concordance of 0.17, much less than in the IBD
segments declared by ANCHAP. As expected, the concordance for the control
segments is uniform throughout the segments. Stage III of ANCHAP generally
gives better concordance. There is poor concordance close to borders of IBD
segments identified in Stage I.
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Figure 3.3 shows concordance (C, defined in Equation 3.5) between exome
SNPs in regions declared as IBD in array data. IBD regions contain fewer oppos-
ing homozygotes than control regions, as depicted in Figures 3.3a and 3.3b. In
control regions, the concordance per SNP is 0.18, whereas in IBD regions 0.99 for
round 2 in Figure 3.3a. Among the shorter IBD regions, there are some where
the exome data suggest they are not IBD, as shown by large standard devia-
tion of error rates, however mean concordance remains at 0.95 even for shortest
segments. When IBD threshold is expressed as a number of SNPs in a segment
(Figure 3.3a), opposing homozygotes occur only in the shortest segments, but
they do occur more often even in longer segments as measured in centiMorgans
(Figure 3.3b).
Stage III of ANCHAP reduces not only the mean number of mismatches be-
tween sequence segments, but number of outlier segments with very large num-
ber of mismatches. Concordance decreases most rapidly with segment length
expressed as number of array SNP. Segments longer than 300 markers, which
also are longer than 2 cM in round 2, give concordance of 0.98.
Figure 3.4 shows concordance in different parts of the genome, and compares
it with the IBD density. On this dataset, in which SNPs are sparser than the
one used in Chapter 2, we can still observe peaks of IBD on chromosomes 2 and
6. Interestingly, in the peak on chromosomes 2 and 6 the concordance is typical,
within one standard deviation from the mean observed genome-wide. This implies
that the peaks of IBD on chromosomes 2 (lactase region) and 6 (HLA region) are
genuine, rather than being artefacts of IBD detection.
Figure 3.5 shows concordance with respect to positions within the IBD seg-
ments. We could expect to see more of the inconsistencies towards edges of the
segments where IBD status is less certain. This can be observed in results for
both Stages I and III of ANCHAP. The results justify trimming 50-100 SNPs
(5-10e7 bp) at segment borders in round 1, and 25 (2.5-10e7 bp) in round 2.
However, in round 2, concordance is high even close to the segment borders.
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3.3.2 Resequencing optimization
The inferred shared haplotypes in an isolated population can be exploited to
increase the efficiency of a sequencing study given a fixed budget. One pos-
sible strategy is to identify an optimal subset of individuals for resequencing
at high coverage so as to obtain accurate sequence data, then to impute these
sequences into the other cohort members with whom they share IBD. For the
selection of individuals, our algorithm favours individuals who share the largest
regions IBD with individuals who were not chosen for resequencing. We have
examined the strategy based on resequencing an optimal 20% of individuals from
ORCADES, which would reduce the cost fivefold, with 65% of the unsequenced
diploid genomes sharing with the sequenced individuals. Had we chosen the indi-
viduals randomly, the IBD coverage of unsequenced haplotypes would have been
61 %, as shown in Figure 3.7.






























Figure 3.6: Proportion of haplotypes sequenced with respect to proportion of
samples sequenced. The curves are affected by relatedness of individuals in a
population, and fraction of samples that were added to a study.
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Figure 3.7: Comparison of the algorithm for selecting individuals against random
choice - proportion of haplotypes sequenced with respect to proportion of samples
sequenced in ORCADES. If samples are selected according to our procedure,
the proportion of haplotypes sequenced is always higher than when samples are
chosen randomly. For example, when resequencing 20 % of individuals in a study,
coverage of haplotypes would be 65 % if individuals are chosen using our method
and 61 % if they are chosen randomly.
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3.4 Discussion
3.4.1 Implications for the algorithm of ANCHAP
Exome sequence data show that the IBD segments inferred by the Stage III of
ANCHAP are more accurate than ones from Stage I. Trimming borders of the
segments in Stage I is definitely necessary, and may still remove errors in IBD
segments from Stage III.
Concordance rates (C) in the IBD segments vary throughout the genome.
This could be a statistical variation arising from a limited number of sequenced
samples. Alternatively, the variation of concordance could be a reflection of fea-
tures that vary throughout the genome. For example, if in some regions the
detected IBD segments date to more ancient ancestors than in other, more mu-
tations might have accumulated. Alternatively, regions of genome with higher
concordance could be ones where IBD is falsely detected, for example in regions
of poor SNP coverage, or where SNPs are not informative, for example where the
minor allele frequencies are very low.
3.4.2 Exome sequence data evaluated against IBD seg-
ments from array data
Shorter inferred IBD segments show lower concordance with sequence data than
longer ones. This could be because shorter IBD segments are more difficult to
detect accurately, as they contain fewer array SNPs. Alternatively, for shorter
segments the common ancestor was more ancient and mutations were more likely,
which reveals itself in opposing homozygotes between sequence genotypes. The
relation between length of IBD segments, time to the common ancestor and mu-
tation rates is further commented on in the Discussion of this thesis.
3.4.3 IBD-based imputations
The example in Figure 3.8 shows a sample imputation for an individual with three
sequenced haplotype sharers. IBD sharing between array SNPs 1 and 2 had been
established between the individual and its three haplotype sharers based on the
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array data. If any of the sharers carries an a polymorphism in one locus, there
is 50% chance the child will carry it too. If any of the haplotype sharers is
homozygous on some rare variant, there is 100% chance the child would carry
it too. If there are few haplotype sharers, we could calculate probabilities of
alleles that the individual carries, based on sharers’ genotypes. The resulting
sequence-SNP genotype will not be phased, and would contain probabilities of
having certain rare variants.

























Figure 3.8: Imputation for an individual with three sequenced haplotype sharers
When we know the phase of the SNP genotypes, there is more information for
IBD-based imputations. Haplotype sharers of an individual can be divided into
two groups corresponding to the two proband’s gametes, and often this reduces
the number of imputation possibilities. Figure 3.9 shows imputation using phase
information for SNP data. With the phase information, the middle locus which
couldn’t be imputed before, can be imputed.
A number of factors determine the accuracy of imputations based on IBD,
as described above. Firstly, only correctly detected IBD would result in correct
imputations. Secondly, a variant could be correctly imputed only if it is older than
the most common ancestor from whom the haplotype was co-inherited. Longer
haplotypes shared IBD should allow for more accurate imputation than with
shorter segments for which the common ancestor was much more ancient. Thirdly,
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Figure 3.9: Imputation is facilitated when the haplotype sharers are split into
two groups (see the middle locus).
imputation relies on the presence of homozygotes among the haplotype sharers,
and often more than one sharer is needed, which is not taken into account in the
selection algorithm (Algorithm 3.2). Finally, the ease of sequence imputations
with the IBD sharing information depends on whether the sequence data can be
phased, and whether it is possible to overlay the array and sequence haplotypes.
There is work in progress both on algorithmic and laboratory methods for phasing
of sequences (Browning and Browning, 2011b). If the sequences are not phased,
the IBD sharing can still be exploited for imputation, but this would result in
more uncertainty about imputed alleles.
For some rare, very recent variants, their carriers should have a recent common
ancestor, and all share IBD in the region with each other. If this is identified by
ANCHAP, and a haplotype of an unsequenced individual also belongs to such a
cluster, he almost certainly also carries the variant. This approach would rely on
detecting IBD clusters, and ANCHAP revealing recent IBD alongside parent-of-
origin for each segment.
The imputation approaches described so far rely on identifying homozygous
minor allele genotypes, which may be very rare, and therefore such approaches
may be infeasible. For example, in the exome data from the ORCADES study, less
than 3% genotypes are homozygous on minor allele. With the approach that relies
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on IBD clusters, we could make use of heterozygous genotypes among sequenced
individuals. If a group of genotypes are all IBD in a region, and they all share
at least one copy of the minor allele, it is very likely that the shared haplotype
contains the rare variant. A similar approach to detecting carriers of Mendelian
variants is presented in Chapter 5. Success of this approach to IBD-informed
mutations would depend on whether the carriers of rare variants among sequenced
individuals indeed share IBD with each other in relevant genomic regions, and on
how old a mutation is.
3.4.4 Accuracy of short-range imputations
Accuracy of the short-range imputation program IMPUTE2 was analysed on the
same data set (Joshi et al., 2013). Accuracy was measured by r2 correlation
between sequence genotypes and ones obtained by imputations using data from
1000 genomes project (Consortium, 2012). The accuracy varied heavily based on
allele frequencies. The r2 values were as follows:
• Minor Allele Frequency 1%− 3.2%: 0.753
• MAF 3.2%− 10%: 0.867
• MAF 10%− 32%: 0.931
• MAF > 32%: 0.944
The performance is generally very good, however accuracy could be improved
for SNPs with low minor allele frequencies. This is because either the model in
IMPUTE2 is not capable of capturing long-range haplotypes, or the rare variants
can be absent from the reference panel altogether. Imputations based on IBD
could help with imputing rare variants, which are possibly newer than others,
and can only be distinguished by long-range haplotypes. Because samples were
selected for resequencing using our algorithms, the imputation accuracy was likely
better that if they had been selected at random.
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3.4.5 Alternative resequencing strategies
An alternative strategy would be to resequence the entire cohort at low cover-
age, then exploit IBD sharing to combine data from all individuals who share
a haplotype IBD to infer an accurate sequence for this haplotype. For instance,
current resequencing methods typically require at least 40 x coverage for accurate
sequence imputation. With an average of four haplotype sharers for each gamete,
it would be sufficient to type all of the individuals at 10 x coverage.
3.4.6 Utility of IBD-informed optimisation of resequenc-
ing studies
We showed that samples in the individuals in the ORCADES study share large
fragments of haplotypes IBD, and the inferred IBD segments are accurate when
evaluated against sequence data. In this section we argue whether the inferred
IBD contributes to optimising resequencing studies and imputations.
Gusev et al. showed vast amounts of recent IBD in Kosrea, and many else-
where unknown variants (Gusev et al., 2012). Also, much recent IBD was iden-
tified in data from ORCADES. In IBD segments, the concordance of sequence
data is nearly perfect for longer IBD segments, is lower at region boundaries, and
varies moderately throughout the genome. Where IBD segments are found, they
are accurate, and there is good potential for imputations.
The identified identity by descent is useful for optimising the design of rese-
quencing studies. We have shown it through increased IBD-coverage compared
to random selection or one informed by genomic relatedness. Gusev et al. also
showed this by improved imputation performance in simulations, using Beagle
imputation software. In ORCADES, when resequencing 20% of samples from an
original study, we could cover 65% of haplotypes when selecting samples based
on their IBD sharing. Had we chosen them randomly, we would cover on average
61%. One could argue our selection algorithm brings only a small improvement,
whereas Gusev at al. showed more impressive improvement in imputation qual-
ity. In the isolated population of Kosrea, 60% of variant alleles could be imputed
with sequencing data from random 1.7% of cohort, or 1.3% if the samples were
chosen by the algorithm. In case of the latter study, the good improvement could
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be because only seven samples were selected, and it is important that they con-
tain several popular haplotypes. In the case of ORCADES, 20% of the original
study corresponds to 180 samples. Even if these are selected randomly, there is a
good chance they will cover haplotypes popular in the isolate. Our algorithm is
capable of picking individuals who carry moderately popular haplotypes, which
however has less contribution to the overall performance score.
Once samples for resequencing are selected and sequence data is available,
we focus on accurate imputations. The accuracy of exome imputations using
IMPUTE2 in the individuals from ORCADES is generally good, but could be
improved for less common and rare variants. It could be improved with IBD-based
imputations, thanks to the abundance of IBD identified from array data and its
high concordance with sequence data. However, naive IBD-imputation algorithms
would fail to deliver the promised improvement in imputation accuracy.
An IBD-based imputation algorithm would need to extract all available in-
formation from the sequence data. An algorithm that imputes a rare variant
in an individual only when his haplotype sharer is homozygous for a rare allele
will fail, since genotypes will be very rarely homozygous for rare alleles. If for
example we decide to sequence n optimal 20% of individuals from ORCADES,
65% of haplotypes would be sequenced either directly (20%) or through a sharer
(45%). However, if we assume there is exactly one sharer of the haplotype, and
we use allele frequencies from exome data, only 3% of the 45% could be imputed.
A IBD-based imputation algorithm would need to use not just homozygous geno-
types among the sequenced individuals, but also heterozygous ones, as described
in Chapter 4.
Before such an IBD-based algorithm is developed, standard imputation strate-
gies, which do not utilise full potential of the data, may be used. In Chapter 4
we demonstrate that IBD-based imputations of rare variants are important for
identifying carriers of Mendelian subtypes of diseases.
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Chapter 4
Identity by descent for
identifying Mendelian subtypes
of diseases - colorectal cancer
4.1 Introduction
Lynch syndrome (LS, hereditary nonpolyposis colorectal cancer) is a Mendelian
form of colorectal cancer (CC), caused by loss-of-function variants in DNA mis-
match repair (MMR) genes: MLH1, MSH2, MSH6, and PMS2 (Lynch et al.,
2009). It is important to detect LS carriers among new CC patients because
it has implications for their clinical management. More extensive resection and
more intensive follow-up screening is indicated in LS carriers, because of the in-
creased risk of new primary tumours in the unresected colon and in other organs
(Vasen et al., 2007). Relatives of Lynch syndrome carriers who share the disease-
causing variant also require screening and follow-up to detect cancer at an early
stage (Lynch and de la Chapelle, 1999), (Moreira et al., 2012). LS is difficult to
diagnose ”as there are no specific clinical or histo-pathological features” (Lynch
et al., 2009). Current methods for detecting LS carriers rely on clinical informa-
tion and tumour biomarkers, however they have serious limitations (Barnetson
et al., 2006), (Moreira et al., 2012), (Aaltonen et al., 1998).
It is likely that a high proportion of the LS mutations arose only once in history
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(Lynch and de la Chapelle, 1999), thus they lie on ancestral haplotypes and the
patients that inherited them are distantly related. Thanks to genotype data
from modern SNP arrays and algorithms for detecting recent identity-by-descent
(IBD) (Kong et al., 2008b), carriers of same LS mutations can be identified.
Furthermore, we can detect IBD in risk regions between known LS carriers and
new colon cancer patients, which is indicative of the latter carrying LS mutations.
Where several unrelated colon cancer patients share IBD at MMR genes, they
could carry a novel LS mutation.
The novel methodology involves first computing similarity measures of SNP
genotypes in regions containing known LS genes through inference of recent IBD.
Secondly, a predictive model takes into account possible inaccuracies in the de-
tection of IBD segments.
Outline We describe methods for detecting haplotypes co-inherited from recent
common ancestors from SNP data, and build a predictive model for LS carrier
status among CC patients. We show feasibility of the approach, quoting accu-
racy of Lynch syndrome prediction, and conclude that the method is promising
especially when extensive amounts of genotype data will be available in biobanks.
4.2 Materials and Methods
4.2.1 Collection of genotypes of patients with Lynch syn-
drome - MOMA
Genotype data for Lynch syndrome carriers was collected in the MOMA (Modifier
of MMR alleles) study, whose aim is to identify the modifiers of mutant alleles of
DNA mismatch repair. The main inclusion criterion was that participants must
be carriers of pathogenic mutations in one of the DNA mismatch repair genes,
and samples in Phase 1 were partly selected for extremes of phenotype and age of
onset. Individuals were recruited to the study either because of family history of
colon cancer with early onset at the time they or their relatives were diagnosed
with the disease, or from prospective studies.
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For all of them, genes involved in MMR were sequenced, so the MMR mu-
tations are known independently of array data. The records of mutations the
individuals carried follow the standard nomenclature for description of sequence
variations (Den Dunnen et al., 2000) . For example, ”c.116G>T” denotes that
116th nucleotide in coding sequence of MLH1 was T instead of G.
Among three platforms used in this study, most MLH1 mutation carriers in
Phase 1 were genotyped with the Illumina HumanHap660W array, and therefore
we focused on this part of the data. The subset of samples we study here consists
of 511 individuals (184 from Scotland, 57 from Melbourne, Australia, 136 from
Newcastle, Australia, 136 from the Netherlands), 456 of which had mutations in
MLH1.
4.2.2 Collection of genotypes of patients with colon cancer
- SOCCS
The Study of Colorectal Cancer in Scotland (SOCCS) is a case-control study of
3,400 prospectively collected colorectal cancer cases from all Scottish hospitals,
and 3400 matched controls. In the first phase of the study 976 early-onset cases
and 1,002 matched controls were genotyped with the Illumina HumanHap550
array (Tenesa et al., 2008). The patients had no known family history of colon
cancer.
The majority of the samples (more than 80%) underwent the procedure for
identifying Lynch syndrome mutations in germline DNA (Barnetson et al., 2006).
To detect mutations, 16 exons of MLH1 were analysed with denaturing high-
performance liquid chromatography analysis to detect single-base substitutions,
insertions and deletions (Wagner et al., 1999). Variants noted there were se-
quenced, as were MLH1 exons 8, 12, and 15 in every sample. Additionally, in
most samples the MMR genes were checked for large deletions using multiplex
ligation-dependent probe amplification. When the procedure was positive, sam-
ples were removed from SOCCS study, so in theory there should be no remaining
LS carriers. For majority of patients also information on tumour biomarkers is
















Figure 4.1: A diagram showing the data set merged of MOMA and SOCCS
studies.
4.2.3 Merging the dataset
Genotypes from the two sources were merged, and markers missing more often
than 1/10 were removed from the compiled set. Strand inconsistencies were
removed using Plink software. This resulted in a MOMA-SOCCS dataset with
508854 markers and 2489 individuals, summarised in Figure 4.1.
4.2.4 Inference of IBD from multi-locus SNP genotypes
In order to infer sharing of LS alleles, identity-by-descent around MMR genes
between multi-locus genotypes was detected using software package ANCHAP
(Glodzik et al., 2013). In the first stage of ANCHAP’s algorithm, large genomic
regions without opposing homozygotes are detected, in the second stage shared
regions are assigned to one of two gametes, and they are used for phasing of the
genotypes. In the last stage, all of the resulting haplotypes are compared to find
regions identical by descent with greater accuracy. In stage I, we searched for
matching genotype sequences longer than 2 cM. Alignment in stage II was with
standard parameters. In stage II, the program identified identical haplotypes
longer than 1 cM and containing 200 phased alleles. This is a shorter genetic
region than standard settings (2 cM), but since data available had more markers
than in the article describing the method, we utilised it and set a threshold for
number consecutive SNPs with phased alleles in a segment to 200 (originally 100).
84
ANCHAP was our preferred algorithm over GERMLINE (Gusev et al., 2009)
because the genetic data in the study is unphased, and over fastIBD (Browning
and Browning, 2010), whose performance we evaluated and found it matches
ANCHAP only when its parameters are tuned. We applied fastIBD with various
values of the scale parameter which controls complexity of haplotype model, and
show the results for the smallest and larger recommended values of the parameter
and for the best performing one.
We visualised the IBD covering whole of each MMR genes by graphs, where
nodes represent individuals and links signify sharing IBD between them (Gansner
and North, 2000).
4.2.5 Predictive model for carrying LS mutations
The predictive model allows to compute probabilities of carrying LS mutations,
by considering IBD shared by a proband with all known LS carriers. In this
model, the probability of sharing a LS mutation, given the length of a segment
IBD, is parametrised. The longer the IBD segment, the more recent the common
ancestor was, and the more likely that the DNA in the shared region is identical.
We define φi,j as probability that samples i and j are IBD in a genetic risk
region. IBDi,j is length of identical haplotypes [cM] spanning the region declared
by ANCHAP. a, b and c are real-valued parameters to be learned from the data.
φi,j = c× logistic(a+ b× IBDi,j) =
c
1 + e−(a+b×IBDi,j)
We build a predictive model on the intuition that a proband carries a LS
mutation if he shares the disease haplotype in MLH1 gene with at least one LS
carrier, and does not share the disease haplotype with controls. Some haplotypes
are particularly common, and may be shared by individuals with and without
the LS mutation present. To eliminate their impact, we use IBD between a new
patient and SOCCS controls. If the patient shares IBD with several LS carriers,
as well as SOCCS controls, this casts doubt as to whether the patient also carries
LS mutations. Let Li = 1 denote that proband i carries a LS mutation, C a set
of LS carriers in training set, and O set of SOCCS controls in training set.
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Pr(Li = 0) ∝
∏
c ∈ C (1− φi,c) , β (4.2)




In order to reduce the dependency of the model on close relatives, and ensure it
generalises on new patients, who are likely to be unrelated to known LS carriers,
when predicting whether a proband carriers a LS mutation, we ignored his close
relatives. In products in Equation 4.1, for each predicted patient, we consulted
data on only such patients in the training set whose genetic relatedness with the
predicted patient is less than a threshold. In experiments we evaluated effects of
different thresholds for genetic relatedness. Furthermore, we decided to exclude
non-Scottish carriers from the data used for model learning, as otherwise the
model might learn to predict Dutch or Australian ancestry, rather than LS carrier
status. We trained and evaluated the predictive model on the set of 181 Scottish
MLH1 LS carriers and 976 SOCCS controls who we assume do not carry LS
mutations.
4.2.7 Computation of genetic relatedness matrix
Genetic relatedness was computed as a matrix of dot products of normalised
genotype vectors (Yang et al., 2010). Accordingly, average relationship between
pairs is 0 and average relationship of an individual with himself is 1. In Equation
4.3 Aj,k denotes genetic relatedness of individuals j and k, N is the number
of SNPs in each genotype vector, and xj and xk are the genotype vectors for
individuals j and k, where allele dosages had been normalised with respect to





xj · xk (4.3)
4.2.8 Cross-validation
To train and evaluate the model we used a cross-validation procedure. We run
cross-validation with 10 folds, in each choosing different 1/10 of data to be the
test set, and the rest to be training set. Based on this, we make predictions on
test data in each fold, and finally evaluate the overall procedure. This rigorous
cross-validation procedure should ensure that the predictions made on unseen
data, SOCCS cases, are of similar quality.
4.2.9 Learning
We selected model parameters (a, b, c) to maximise likelihood on training data, in
each fold. We optimised the likelihood using a constrained active set optimisation
algorithm as implemented in Matlab, with starting parameters set randomly in
the region of high-likelihood (−2 > a > −50, 2 < b < 50, 0.01 < c < 0.99),
chosen from a prior visual inspection of the likelihood surface.
4.2.10 Predictions on colon cancer patients and verifica-
tion
Finally, we make predictions of LS status for new CC patients, whose LS status
is unknown. We do this using the predictive model optimised using all training
data. By reference to the haplotype sharers of a proband, the algorithm also
highlights a likely mutation and its location in the MLH1 gene.
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4.2.11 Verification of the suspected patients by Sanger
sequencing
For top indicated patients, the predictions were verified by targeted dideoxy
Sanger sequencing in indicated exons. As positive controls we used samples from
the MOMA study which had been confirmed to carry the same mutations as the
suspected patients. Additionally, we looked up the mutations identified earlier
in the original sequencing of the MLH1 gene in SOCCS study. This work was
carried out by Susan Farrington.
4.3 Results
4.3.1 Lynch syndrome carriers share IBD around the MLH1
gene
Figure 4.2 illustrates identity-by-descent of long haplotypes between individuals
with MLH1-related Lynch syndrome. Throughout MLH1 LS carriers share IBD
around 9 times more often than SOCCS controls, and 4.5 times more often than
the same LS carriers elsewhere on chromosome 3. Because on chromosome 3
there are no other regions of increased IBD sharing like at MLH1, frequent IBD
sharing at MLH1 between LS carriers cannot be explained by relatedness alone,
but rather by sharing the disease haplotype.
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Figure 4.2: Frequency of IBD sharing on chromosome 3, with MLH1 marked
by the vertical line. The horizontal axis shows genetic position on chromosome
3, and the vertical axis shows sharing density, or the probability that a pair of
individuals share IBD at a locus. Only sequences longer than 2 cM are plotted.
LS carriers share IBD around the MLH gene more often than elsewhere on the
chromosome. There is almost no sharing between controls.













































































































































































































































SOCCS: cases SOCCS: controls LS carriers: SCO LS: OZ, mel LS: OZ, new LS: NL
Figure 4.3: IBD graph for the MLH1 region, where edges denote IBD relation-
ship longer than 3 cM. Each node in this figure represents a patient or Lynch
syndrome carrier, and shown are only individuals who share a haplotype with
at least one other sample. Green nodes represent Scottish colon cancer patients
and controls. Other colours represent Lynch syndrome carriers from different ge-
ographic locations. Where two nodes are connected, this indicates that the two
patients share region including MLH1 gene IBD. Clusters of patients (identified
with labels) indicate groups that carry same LS mutations. Where a Scottish
colon cancer patient falls into a cluster of LS carriers, we infer the patient could
be an unsuspected LS carrier.
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4.3.2 Evaluation of recent IBD against mutation informa-
tion
Further validation is provided by resequencing data available for the LS carriers
in the MOMA study, through which mutations in MLH1 had been identified. We
defined sensitivity as a ratio of pairs who were found to share IBD at MLH1 to
number pairs of individuals who share the same LS mutation:
number of pairs that share the same LS mutation and share IBD at MLH1
number of pairs that share the same LS mutation of MLH1
False discovery rate is the ratio of number of pairs of individuals that share IBD
at MLH1 despite not having the same LS mutations to the number of pairs of
individuals that were found to share IBD at MLH1:
number of pairs that share IBD at MLH1 and have different LS mutations
number of pairs that share IBD at MLH1
IBD sharing between a pair that carry two different LS mutations could arise if
the two individuals share the non-disease haplotype IBD.
We evaluated whether pairs identified to share IBD around MLH1 also carry
the same LS mutations, and present the result in Figure 4.4. For sequences longer
than 3 cM, sensitivity and false discovery rate are 0.51 and 0.1, for sequences
longer than 2 cM they are 0.60 and 0.13 respectively. Below this threshold more
errors occur, such that for all sequences longer than 1 cM the sensitivity reaches
0.65 and false discovery rate 0.28. Using the same reference data we compared
the performance of ANCHAP against fastIBD, another algorithm for detecting
recent IBD, and found that it matches the performance of ANCHAP only with
most optimal non-standard settings. Overall, there is agreement between the
IBD segments and the mutation annotation, but also considerable amount of
uninformative IBD sharing that the predictive model needs to deal with.
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fastIBD scale 3.5
fastIBD scale 2.0 (dafault)
Figure 4.4: Evaluation of IBD detection between carriers of LS mutations in
MLH1 against mutation information obtained from sequencing of the gene. We
checked whether pairs that share IBD at MLH1 also carry the same mutations.
With decreasing length of IBD segments, concordance with mutation information
drops. In the comparison of methods ANCHAP performed as well as fastIBD with
the optimal scale settings.
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4.3.3 Relatedness and length of IBD segments
New patients diagnosed with colon cancer are likely to be related with known LS
carriers only distantly. To be able to use IBD with LS carriers as a diagnostic,
we should be able to find also unrelated pairs who share IBD in the risk region.
Figure 4.5 shows this is the case. Even though there are many closely related pairs
of Lynch syndrome carriers, there are also nearly unrelated patients who share
large segments (8 cM) that spans MLH1. IBD can be observed among pairs where
one individual is a LS carrier and second is a SOCCS case, and among LS-SOCCS
control pairs. Longest segments (>3 cM) are between LS carriers and SOCCS
cases, however also present are shorter segments (<2.5 cM) of haplotype identity
between LS carriers and SOCCS controls. In summary, at MLH1 there are long
haplotypes shared IBD between nominally unrelated individuals, as required by
out method for detecting carriers of LS mutations.
4.3.4 Quality of predictions of Lynch syndrome
In order to detect unsuspected LS carriers among new colon cancer patients,
we learned parameters for a predictive model. Predictions that are made by
the model on test data are illustrated in Figure 4.6. The model identifies the
majority of LS carriers in the MOMA set. Performance of the predictive model
is summarised in Figure 4.7. When all, also related individuals from the training
data, are used for making predictions on test data individuals, the area under
the ROC curve is 0.91, and it drops to 0.83 when only individuals whose genetic
relatedness with a tested patient is less than 0.05 are used. Predictions are very
accurate, however the performance does depend on whether close relatives are
used in the analysis.
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Figure 4.5: Genomic relatedness and the length of segments shared IBD around
MLH1. Some pairs of LS carriers (LS pairs) share long regions IBD at MLH1,
even though their genome-wide relatedness is low (< 0.05). Accordingly, we can
expect to find long IBD regions between unrelated pairs of known LS carriers and
new colon cancer patients.
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Figure 4.6: Predictions on test data using top model.
Top figure: true LS carrier status for samples, where blue denotes that mutation
present.
Bottom figure: predictions for LS carrier status made by the model
The model detects many of true LS carriers, and assigns low probabilities of LS
to SOCCS controls, who have not developed colon cancer. The good quality of
predictions is summarised by the ROC curve, area under which is 0.85.
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all samples used, AUC: 0.91
non−related samples (genetic relatedness <0.1), AUC: 0.85
non−related samples (genetic relatedness <0.05), AUC: 0.83
clinical info and tumour biomarkers: MSI
clinical info and tumour biomarkers: IHC
Figure 4.7: ROC curves for the predictive model, on test data. Also plotted is
performance of Bethesda and Modified Amsterdam criteria, which need clinical
and family information and are currently used in clinics. With all samples used,
the performance of our model is similar to one that uses clinical data and tumour
information.
4.3.5 Comparison against currently used diagnostics
For comparison, Figure 4.7 shows performance of other available diagnostics. At
the extremes of our ROC curves we see the Modified Amsterdam and Bethesda
criteria, which are based on the disease history in the family and clinical infor-
mation like presence of microsatellite instability in the tumour. With all samples
used, the performance of our model is similar to performance of predictive model
that uses clinical information and tumour biomarkers.
4.3.6 LS predictions for colon cancer patients
Finally, we used the predictive model to rank colon cancer patients in SOCCS
study as unsuspected cases of Lynch syndrome. Table 4.1 shows a list of individ-
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uals to whom the model assigned probabilities for carrying LS mutations more
than 0.8. Indeed, the three individuals there, ones identified as: ”7335”, ”1863”,
”2665”, could also be identified visually from Figure 4.3, because they share IBD
around MLH1 with Scottish samples who share IBD also between each other.
The remaining five candidate individuals that were predicted to carry LS muta-
tions shared shorter haplotype segments, and therefore they were not shown in
the Figure.
patient Number of IBD sharers, LS carriers LS mutations Number of IBD sharers, controls
ID segment length of IBD sharers segment length
3 cM 2cM 1.5cM 1cM 0.5cM 3cM 2cM 1.5 cM 1cM 0.5cM
7335 6 6 6 15 16 c.116G> T 0 0 0 1 3
1863 6 6 6 6 18 c.116G>T 0 0 0 0 3
1873 0 0 0 0 20 c.116G>T 0 0 0 1 3
5021 0 0 0 0 16 c.116G>T 0 0 0 1 3
2665 3 3 4 5 10 c.1190 1191delT 0 0 0 1 8
7008 0 0 3 3 4 H264R 0 0 0 0 2
1808 0 0 0 2 4 EX1del 0 0 0 0 0
2631 0 0 2 2 3 c.116 +1G>A 0 0 0 0 0
Table 4.1: Top colon cancer patients suspected of carrying the LS mutations,
their IBD sharing with known LS carriers and controls, and the mutations in
MLH1 they could carry.
4.3.7 Search for novel Lynch syndrome mutations
Figure 4.8 shows a cluster of SOCCS patients that all share IBD with each other,
without sharing with any known LS carriers. We suspect that these individuals
carry novel LS mutations. On chromosome 3, the individuals share IBD only
around MLH1. The cluster also includes on SOCCS control who may also be
carrying the mutation, which is not fully penetrant.
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A cluster of SOCCS cases sharing haplotypes IBD longer than 3 cM with each
other around MLH1.
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SOCCS controls density (note scale)






















Cluster IBD density MINUS SOCCS controls density








SOCCS cases less SOCCS controls
Figure 4.8: A demonstration of detecting possible carriers of unknown mutations
in MMR genes among colon cancer patients. On chromosome 3, four unrelated
SOCCS patients and one control share IBD only around the MLH1 gene. Almost
all pairs of cluster members share IBD between each other around MLH1, which
implies sharing a common haplotype. IBD sharing of long haplotypes between
unrelated samples is unlikely, and indeed this does not happ n outside the vicinity
of MLH1, as shown by the middle plot. Bottom plot shows that background rates
of sharing such long haplotypes IBD among the controls are negligible. The five
samples are therefore suspected of carrying a novel LS mutation.
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4.3.8 Verification of Lynch syndrome carrier status of sus-
pected patients through targeted sequencing
None of the suspected eight patients was found to carry the predicted mutations
in MLH1. Some other variants in MLH1 were observed, for example IVS 14-19
SA a>g, IVS 13+14 SD G>A or I219V, as shown in Table 4.2. IVS 14-19 SA
A>G stands for A to G mutation of 19th last nucleotide of intron 14 of MLH1
(Den Dunnen et al., 2000), IVS 13+14 SD G>A stands for G to A mutation of
13th nucleotide of intron 13, and I219V denotes change of isoleucine to valine at
219th amino-acid of the MLH1 protein. The SOCCS patients who all share IBD
with each other carry variants are also listed in Table 4.2.
patient ID LS mutation suspected mutation confirmed other variants in MLH1
Patients suspected because of IBD with known LS carriers
7335 c.116G> T Scotland No -
1863 c.116G>T Scotland No IVS 14-19 SA a>g
1873 c.116G>T Scotland No -
5021 c.116G>T Scotland No I219V, IVS 14-19 SA a>g
2665 c.1190 1191delT Scotland No I219V, IVS 14-19 SA a>g
7008 H264R Oxford Not screened
1808 EX1del Scotland No IVS 13+14 SD g>a
2631 c.116 +1G>A Scotland No -
Patients suspected because their share IBD with each other
2965 unknown I219V, IVS 14-19 SA a>g and IVS 9+10 SD a>g
2593 unknown I219V, IVS 14-19 SA a>g
1991 unknown I219V
2966 unknown I219V, IVS 14-19 SA a>g
Table 4.2: Resequencing of MLH1 from top suspected SOCCS patients was not




4.4.1 Spectrum and inheritance of Lynch syndrome mu-
tations
For new LS carrier detected with our method, the suspected patient has to carry
the same mutation as at least one known LS carrier, and share a long haplotype
with him. Carriers of private mutations cannot be detected in this way.
It is probable that most LS mutations are not private variants but are shared,
based on frequencies of mutations in MOMA study. Firstly, the samples in
MOMA studies come from only 3 countries, where the pool of mutations may
be limited. Secondly, as discussed in the introduction, LS mutations are unlikely
to affect reproductive fitness and thus are not removed by selection. To check
these assumptions, we analysed the frequencies of LS mutations in the MOMA
study, as shown in Figure 4.9. Only 20-24% of mutations occur only once, and
some mutations are particularly common.
Many participants of the MOMA study had been recruited because they had
affected family members, and therefore we may have a biased view of the pro-
portion of mutations that are shared. In building the predictive models we took
steps to reduce the effects of such a design of the study, by ignoring close family
members based on genetic relatedness. The reported accuracy of the model may
still be unrepresentative of how it would perform in general, as the proportion of
shared to private mutations may not be general for the whole population. This
problem would be ameliorated if a larger proportion of LS carriers were sequenced.
4.4.2 Assumption of high penetrance of Lynch syndrome
variants
Our validation study assumes that the control individuals in SOCCS study do
not carry any LS mutations, however in reality mutations of low penetrance could
occur even among individuals who did not develop colon cancer. In such case LS
carriers could occur even among SOCCS controls, and our experimental design
would be inappropriate. We hoped to sequence the three SOCCS control individu-
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Figure 4.9: Ordered frequencies of Lynch syndrome mutations in MLH1. Left:
whole of MOMA study, right: Scottish carriers only. In both cases there exist
some very common mutations. In the whole of MOMA study 20% of carriers
carry singleton mutations, and among the Scottish carriers 24%. The remaining
mutations are shared between two or more individuals, either due to their high
frequency or due to design of the MOMA study.
als whom the model indicated that they could carry LS mutations. Unfortunately
the sequencing of these samples could not be done due to time constraints of our
collaborators.
4.4.3 Accuracy of IBD detection
Accuracy of detected recent identity-by-descent is crucial for predictions of LS
status. For this application, the identical regions should be co-inherited from
a common ancestor more recent than ancestor in whom the LS mutation first
arose. In Chapter 2 as important for accurate detection of recent IBD shown
were accuracy of genetic map and accounting increased linkage-disequilibrium in
some parts of the genome. It is possible that some of the segments we identify as
IBD in reality were inherited from their common ancestor that was earlier than
the ancestor in whom the disease mutation first arose. It has been reported that
dating common ancestors based on length of IBD segments may be imprecise
(Ralph and Coop, 2012). Because unexpectedly we detect some IBD segments
even between LS carriers and SOCCS controls, we may be detecting ancient
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haplotypes that are unusually long. Furthermore, some of the inaccuracies may
result from the border position of the MLH1 gene in many IBD segments. Most
haplotypes shared IBD that span the MLH1 end shortly after the gene. This
could be either because of a recombination hotspot downstream of the MLH1, or
increased linkage disequilibrium upstream of the gene. We showed in Chapter 3
that towards the ends of detected IBD segments, genotypes of sequences match
less often. For pairs where the recent IBD segments cover MLH1 gene only
marginally, LS mutations might not have been inherited. On the other hand, our
predictive model appears to cope with occasionally imprecise inference of IBD,
given its high predictive accuracy on test data.
4.4.4 Sequencing the suspected patients in search for vari-
ants in MLH1
The usefulness of work presented here depends on whether the predictive accuracy
generalises to new colon cancer patients. We resequenced the top colon patients
suspected of carrying LS mutations, as highlighted by our model. Sequencing of
the patients suggested by the algorithm, on the contrary, did not identify any of
Lynch syndrome carriers. Even though the model was very accurate in predicting
LS status on test data, it failed on new colon cancer patients. Possible reasons
for this include:
1. incorrect detection of IBD segments,
2. that the detected IBD segments between are so ancient, that the common
ancestor precedes the time when a given Lynch syndrome mutation arose,
3. sample mishandling: different samples used for SNP genotyping and rese-
quencing,
4. high-performance liquid chromatography not revealing all mutations.
Incorrect detection of IBD segments is unlikely for long shared haplotypes.
IBD segments for the top suspected patient with identifier 7335 are shown in
Figure 4.10. There are hardly any missing genotypes in the genotypes of known
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LS carriers and the suspected ones. I verified that the haplotypes recovered by
ANCHAP for the LS carriers and suspected patients are indeed identical at the
typed SNPs. There are no unusual allele frequencies of SNPs around MLH1.
Additionally, another program fastIBD returned IBD segments very similar to
ones given by ANCHAP.
The most likely source of error is in the assumptions we made. We showed
earlier that the method correctly identifies carriers of the same mutations for
known LS carriers, as in Figure 4.4. However, it does not imply that the method
would work equally well between the LS carriers and new CC patients. IBD
segments are generally shorter for the later pairs. Between the known LS carriers
and new CC patients, we may be detecting sharing IBD of the ancient, shorter
haplotypes that pre-date the LS mutations. This point can be verified from
the data: in Figure 4.11 - pairs of known carriers of the same LS mutation
mostly share longer IBD segments with each other, than with the top 4 SOCCS
patients suspected of carrying the same mutation. Additionally, between known
LS carriers false positive detection of IBD is less probable, as there are fewer pairs
for detecting IBD sharing.
Another reason why we find shared haplotypes between known LS carriers and
new CC patients, but not the same mutations, is that the haplotypes of MLH1
themselves are more prone to mutations, and so increase the risk of colon cancer.
This would explain the lack of indicated mutations among the new CC patients.
However, we have not found any such haplotypes among the known LS carriers,
as they mostly share the mutations when they share IBD around the MLH1 gene.
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Figure 4.10: Illustration of IBD sharing between top suspected patient 7335 from
the SOCCS study, and samples with diagnosed Lynch syndrome. Top figure:
position of IBD segments (X-axis, MLH1 marked with a vertical line), shared with
other samples in the study (Y-axis), ordered from bottom: known LS carriers,
SOCCS cases, SOCCS controls. Bottom figure: length of IBD segments with
known LS carriers, and the mutations in MLH1 they carry. As a result, the
sample 7335 was predicted to carry the same mutation c.116 G> T with high
confidence.
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Figure 4.11: Lengths of IBD segments between the pairs of patients with Lynch
syndrome with mutation c.116 G>T in MLH1, and between them and four
SOCCS patients suspected of carrying the same LS mutation. Known LS pairs
share mostly much longer segments IBD, and are much closely related between
each other.
The sample mix-up might have occurred due to the sheer number of them
handled in the SOCCS study. Identity of sequenced and genotyped samples could
be evaluated if larger portions of the MLH1 gene exons had been fully sequenced.
4.4.5 Predictive model learning
The fact that MOMA samples were recruited from families could not only distort
the results for predictive accuracy of our model, but also affect learning. The
model could learn to depend only on very long stretches of IBD, which in reality
would not be encountered between unrelated LS carriers and a new colon cancer
patient. We attempted to reduce the dependencies on close relatives by restricting
the data set to unrelated individuals.
The IBD segments between known LS pairs are mostly much longer than
with unsuspected LS mutation carriers. From the φ function learnt, as shown
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in Figure 4.12, we see that the model relies on IBD segments 1.5 cM long as
much as on segments 5 cM long. For the data available, it seemed valid, as the
predictive accuracy of the model on test data was very good. On data where real
LS carriers are not from MOMA study, the performance of the model may not
generalise, and longer IBD segments might be required for accurate predictions.
This could be due to different sample sizes or to the partially family-based design
of MOMA. To ensure a better match between test and unseen data, test data
should be composed of LS carriers identified in a prospective study.
Figure 4.12: Phi functions learnt across folds of the model training. Horizontal
axis: length of IBD segments. Vertical axis: value of φ. From the φ function
learnt, we see that the model relies on IBD segments 1.5 cM long as much as on
segments longer than 5 cM.
4.4.6 Suggestions for repeating the experiments
Most of the SOCCS patients had been screened for Lynch syndrome using high-
performance liquid chromatography, sequencing of three exons for everyone and
other exons if the initial screening revealed variants (Barnetson et al., 2006).
Measured were also biomarkers for most of the sample tumours: micro-satellite
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instability and immuno-histochemistry. We aimed to detect Lynch syndrome
carriers missed in this procedure, but very few cases would have been missed.
Out of the 976 cases, we would expect around 30 LS carriers (Lynch et al.,
2009), and among these we expect 11 to carry de-activating mutations in MLH1
(Moreira et al., 2012). In SOCCS, previously reported had been 14 (Barnetson
et al., 2006), they had been moved from SOCCS to MOMA, so the chance that
any undiagnosed carriers remain is low.
In order to properly evaluate accuracy of the predictive algorithm, we could
try to reconstruct the original SOCCS dataset with the 14 prospective LS carriers
in it. The 14 individuals who turned out to be LS carriers could be then taken as
reference LS carriers. However, the 14 individuals are a too small number for a
formal evaluation. I looked into the data on the 14 individuals that were moved
from SOCCS to MOMA after LS was detected. Unfortunately, using our method
only 2 carriers could be detected because they share IBD with other known LS
carriers. A further 4 could be detected, but they have very close relatives in
MOMA as well, probably due to design of the MOMA study. The rest of LS
carriers either have private mutations, or they share IBD regions that are too
short to be picked up by the model from noise.
In conclusion, in order to show the power of the algorithms presented here,
one would require a large study covering a larger sampling fraction of cases. With
higher sampling fraction, many of the singleton mutations in MMR genes might
turn out to be shared.
4.4.7 Detecting novel Mendelian subtypes
Sharing long haplotypes IBD in disease risk regions between unrelated individu-
als could be indicative of unknown mutations causing Mendelian variants of the
disease. When a number of patients all share recent IBD with each other, this
is unlikely to happen by chance. We accessed the initial sequencing information
on the exons of the MLH1 gene from patients in the cluster. We found that the
only variant that they share affects the MLH1 protein by substituting isoleucine
to valine at amino-acid 219 (I219V), or c.655 A>G in nucleotide notation. This
variant is common enough that it was assigned a number rs1799977, and the
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frequency of the G allele is 0.4 in European population. There is no conclusive
evidence on impact of this mutation on the DNA mismatch-repair mechanism.
With this data set, we could not demonstrate that the approach is able to
detect unsuspected LS carriers. This approach could still be examined if a higher
proportion of colon cancer patients are genotyped, giving a chance that the un-
suspected carriers share larger IBD segments with each other.
4.4.8 Possible improvements to the predictive model
The algorithm we presented is a prototype designed for simplicity, which could be
further improved. Other types of φ functions, which we only require are monoton-
ically increasing, could improve predictive accuracy. Further improvement could
be brought by explicit modelling of clusters of identity by descent, through graph
theoretic algorithms, as for example DASH (Gusev et al., 2011).
4.4.9 Prospects for using the method in future
The chance of identifying novel Mendelian subtypes grows with number of sam-
ples genotyped. With increasing proportions of population in biobanks for which
genotype data is available, more recent IBD will be detected, improving predic-
tion accuracy. The number of colon cancer patients in our study is only about
3% of patients diagnosed in Scotland per 10 years (Scotland, 2013). When a
higher fraction of colon cancer patients appears in biobanks, the approach we
demonstrate here is likely to perform better for detecting Mendelian subtypes of





The original motivation for the work described in this thesis was that identical-
by-descent haplotypes capture rare variants. In order to establish utility of IBD
segments inferred from SNP data, we have focused on their use in optimising
resequencing studies, in studying Mendelian subtypes of diseases, and in genomic
predictions. For these applications, utility of the detected IBD sharing depends
on:
• how accurate and complete detection of IBD regions is,
• whether time to common ancestor for a shared haplotype can be estimated,
• how likely are mutations that accumulate on haplotypes since the common
ancestors,
• whether long-range phasing is more accurate than traditional short-range
methods.
We first present preliminary work on genomic predictions that use regions
of recent IBD, since the rare variants that they capture were thought to be the
reason behind missing heritability of many complex traits. In this section we
also discuss the factors that decide on utility of the IBD segments for all of the
mentioned applications. Finally, we predict the future of IBD analysis when
genetic data for a large proportion of the population is available in biobanks.
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5.1 Genomic predictions utilising recent iden-
tity by descent
Missing heritability of quantitative traits could be explained with rare variants
of large effect. Alternatively, common SNPs could explain a large proportion of
genetic variants of traits if the traits are very polygenic and the effects sizes are
too small to reach significance levels in genome-wide association studies (Yang
et al., 2010).
We present preliminary results of our work on genomic predictions here be-
cause more work should be done to complete the experiments. The aim of the
work presented here is to compare predictive models of quantitative traits based
on the two hypotheses, in particular to test whether models that take into ac-
count rare variants predict traits better. One predictive models uses common
SNPs only, and another one uses ancestral haplotypes shared IBD, together with
rare variants that they carry. Building models for genomic predictions is impor-
tant because, among others, it would allow for predicting risk for diseases and
their early prevention.
By comparing the two predictive models, one based on common SNPs only
and one based on haplotypes, we evaluate the additional predictive power rare
variants could have. If the aim was to develop most accurate predictions of traits
and diseases from genetic data, the predictive models would have to become more
complex, for example by learning which genetic variants are important for each
trait or disease.
In the project on genomic predictions I wrote programs to compute genomic
kernels, whereas Athina Spiliopoulou set up the predictive model and experi-
ments.
5.1.1 Polygenic model
Known associated SNPs which exceed genome-wide significance threshold can
explain 10 % of phenotypic variance for height (Allen et al., 2010), 1.45 % for
BMI (Speliotes et al., 2010) and 12.1 % for HDL cholesterol (Teslovich et al.,
2010). SNPs that do not reach the threshold could explain some of the remaining
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variance (Yang et al., 2010).
Yang et al. set up a polygenic model to estimate the variance explained by
common SNPs. The authors utilise a linear additive model of quantitative traits:
yj = µ+ gj + ej
where yj is a measurement of a phenotype, µ is mean, gj is a genetic component





where m is the number of variants affecting the trait, zi,j’s are allele dosages
normalised with respect to the allele frequencies, and ui are the variant effects.
Genetic variance is recovered from this equation, using restricted maximum like-
lihood approach, or equivalently by regressing genomic relatedness of pairs onto
the square of difference of the phenotypic values.
var(y) = Gσ2g + Iσ
2
e
where G is the genomic relationship matrix between pairs of individuals at causal
loci, for which they obtain an estimate by computing dot products between all
available SNP genotypes for pairs of individuals.
With this approach Yang et al. estimate that 0.45 of genetic variance for
human height is explained by common SNPs. Not all of variance is explained,
because some of the rare causal variants are not in LD with the SNP data avail-
able. The authors conclude that the remaining missing heritability is due to rare
variants, some of them in weak linkage with genotyped SNPs. However, the her-
itability computed in this way accounts for only such variants that influence the
traits independently and linearly. Zuk et al. (Zuk et al., 2012) claim that many
of the variants interact in pathways, and therefore estimates of heritability from
relatives and computed as above are inconsistent.
We build a model for genomic predictions borrowing from the polygenic model,
which serves us our baseline for predictive accuracy from common SNPs.
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5.1.2 Kernel-based genomic predictions
The estimate of G, which Yang et al. compute from pair-wise dot-products of all
SNP genotypes, is an example of a kernel. We propose another kernel, one based
on haplotype IBD sharing which should convey sharing of rare variants. We also
describe kernel ridge-regression, with which the kernels can be used for genomic
predictions.
Kernel functions provide a measure of similarity between two items (Hofmann
et al., 2005), in our case between two SNP genotypes. Valid kernels represent
original observations in a different, possibly infinite-dimensional, space. This is
equivalent to the kernel matrix, a result of evaluating the kernel function be-
tween all pairs of items, being positive definite. Valid kernels can be defined not
only between real-valued vector items, but also between other types of data, for
example strings.
As a baseline we used a linear kernel, borrowed from Yang et al. If genotype
vectors of two individuals are denoted as xi,xk, where the allele dosages have been
normalised with respect to frequencies for each SNP, then the kernel function for





We compare this with an alternative kernel based on haplotypes, which implic-
itly conveys the extent to which haplotypes of a pair of individuals are identical
by descent. We compute string kernels on the haplotypes, weighting them so that
sharing a long segment of a haplotype contributes to similarity more than shar-
ing several sub-strings. Given two haplotypes strings (hA,hB), the IBD kernel





where S is a set of identical sub-strings between the two haplotype strings,
with their length being the number of SNPs in an identical region, and p is a
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parameter dictating how much more weighted are longer continuously matching
sub-strings. The kernels between haplotypes are then combined to give a similar-
ity measure between two individuals. If genotype xi consists of haplotypes hi,1
and hi,2, and xk accordingly, the kernel between the individuals is a sum over all
four combinations of haplotypes:
k(xi,xk) = k(hi,1,hk,1) + k(hi,1,hk,2) + k(hi,2,hk,1) + k(hi,2,hk,2)
I have proved that this kernel is positive definite.
In order to build a model for genomic predictions, we plugged both of the
kernels into kernel ridge regression. Ridge regression is a linear regression model,
which can cope with low number of samples compared to number variables thanks
to L2 penalty on sum of squared weights, denoted by λ. It can also be used with
kernel functions, which implicitly represent SNP data in another space. In our
experiments, for training of the model and the predictions we used implementa-
tion of Multiple Kernel Learning, which as a special case includes kernel ridge
regression (Bach et al., 2004). We trained and evaluated the models using cross-
validation. We evaluated quality of phenotypic predictions on the test data by
computing Pearson’s correlation between predicted and measured phenotypic val-
ues.
5.1.3 Genotype and phenotype data
In order to demonstrate the predictive model, we used genetic and phenotypic
data from three Croatian populations. Two of the populations have been isolated
on the islands of Korcula and Vis, and the third group of samples comes from the
mainland city of Split. Overall, 2,186 individuals were genotyped with SNP ar-
rays, such that after standard quality control the intersection of SNPs contained
267,912 SNPs. Available were measurements of the following phenotypes we wish
to predict from genotype data: height, body-mass index (BMI), HDL cholesterol.
Individuals with poor genotyping or phenotypic measurements standing out from
the mean by four standard deviations were removed. HDL cholesterol measure-
ments were log-transformed since after the transformation the distribution of
values resembled normal distribution. All phenotypic measurements were nor-
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malised to a mean of 0 and standard deviation of 1.
5.1.4 Results
On test data, in experiments with height, HDL cholesterol and BMI, we could
not establish with statistical significance that the kernel encoding identity by
descent outperformed the linear kernel. Figure 5.1 shows correlations between
predicted and measured genotypes in a 5-fold cross-validation on validation data.
Because on the validation data we also choose optimal value of the parameter λ,
this experiment could return biased results, performing better than with unseen
data.
Figure 5.1: Correlations between real and predicted phenotype measurements on
validation data. P1, P2, P5 correspond to p in Equation 5.1 taking values 1,
2 and 5 respectively. Kernels based on IBD are not predicting the phenotypes
significantly better than the linear kernel.
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5.1.5 Conclusions
We were not able to answer conclusively whether rare variants as captured by
recent identity by descent matter for genomic predictions. Either the kernel
constructions we proposed are not better at capturing the rare variants than the
linear kernel, or our experiments had too few samples to show this.
Different quantitative traits may be influenced by common SNPs or rare vari-
ants to different extent. Both height and BMI are thought to be highly polygenic,
so the results of our experiments should not be surprising. Fewer variants have
been associated with HDL cholesterol, so it is for this trait that we might have
expected to see an improvement in predictive accuracy with an IBD-based kernel.
A possible problem with the presented experiments is that we give perfor-
mance measures on validation data, which as result could be better than for
unseen data. This problem could be tackled by setting up a fully nested cross-
validation procedure, where performance would be measured on test data rather
than validation data. However, since there is only one real-valued parameter
tuned on the validation data, λ, predictive accuracy on the validation data will
likely generalise to unseen test data.
High relatedness of the samples from the isolated populations could also affect
our results. On one hand, this ensures that there are more segments of IBD which
we could utilise. On the other hand, our model may learn to depend on close
relatives only, rather than to rely on any meaningful, causal genetic variations.
A possible way to check whether this is the case is to remove pairs of very close
relatives from the data and then again assess the predictive accuracy.
Finally, the predictive accuracy of our models could be further optimised.
The models could learn to depend on SNPs or haplotype sharing in the predictive
parts of the genome only. Such models could learn the regional dependencies from
genetic and phenotypic data only, but could also utilise genomic annotations like
information on chromatin structure.
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5.2 Limitations of inference of identity by de-
scent
We could not show the advantages of IBD analysis in genomic predictions over
a simple linear SNP-based kernel. This, and the other presented application
depends on whether the shared haplotypes also imply sharing rare variants. The
shared haplotypes will only capture rare variants when they are recent enough,
which could be estimated from the size of regions shared IBD.
5.2.1 Relationship between lengths of IBD segments and
time to common ancestor
Length of IBD segments given time to a common ancestor can be modelled, from
which we may learn about the reverse problem of dating back segments of IBD. If
we assume that locations of crossover on gametes follow exponential distribution
at each meiosis, and if n is the number of generations to a common ancestor,
then the expected length of a IBD haplotypes is (2n)−1 Morgans, with variance
of (2n)−2.
When trying to estimate time to a common ancestor to an IBD segment,
the problem is the opposite. It may be misleading to date IBD segments based
on their length and the exponential distribution above (Ralph and Coop, 2012).
For example, expected length of an IBD segment given a common ancestor 50
generations ago is 1 cM, but if an IBD segment is 1 cM long, then an ancestor more
ancient than 50 generations ago is likely. This is because as time to a common
ancestor increases, the number of lineages descending from that common ancestor
grows fast. There are many individuals sharing ancient haplotypes, and some of
them may be unusually long. As a consequence the distribution of time to the
common ancestor given length of a haplotype shared IBD is heavily right-skewed
towards older segments.
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5.2.2 Mutation rates in old IBD segments
Older IBD segments that we detect from array data might have accumulated
mutations in the time since their common ancestors, so that apparent IBD sharers
do not share all variants. This would impair utility in such IBD segments in
the applications such as optimising resequencing studies, identifying Mendelian
subtypes of diseases and genomic predictions.
Mutations rates per generation were recently estimated in an Icelandic study
of 78 parent-offspring trios utilising whole-genome next-generation sequencing
(Kong et al., 2012). Average de novo mutation rate was found to be 1.20×10−8 per
nucleotide per generation at parental gametes, and less than third of at maternal
gametes. The rate heavily varied with father’s age, increasing 4.3 % per year.
The estimates indicate that mutations in IBD segments that we detect from
array data are unlikely. With a common ancestor 50 generations ago, the expected
length of an IBD segment is 1 cM, which on average corresponds to 1 Mb. If
we accept Kong’s estimate for mutation rate, the rate of mutation within 50
generations would be still less than 10−6 per nucleotide. We can therefore rely
even on shortest detectable IBD segments, as their sharers share likely all of the
variants.
A different situation may arise in Chapter 4. The Lynch Syndrome mutations
are generally very rare, so their respective mutations might have occurred in near
past. In our method for detecting unsuspected Lynch syndrome carriers we know
that a new patient share IBD with a known carrier who inherited the mutation,
so in other words we condition on the presence of a rare variant. Taking the low
general mutation rate per nucleotide may be misleading for inference of carrier
status this case.
5.3 Advantages of long-range methods for de-
tecting recent IBD
Already existing short-range phasing might have been used for extracting regions
of IBD. Algorithms like Beagle could output haplotypes, and when they con-
tinuously match between samples, we could declare them identical by descent.
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Whether such strategy could be accurate depends on phasing accuracy of short-
range methods.
Phasing accuracy of short- and long-range methods has been compared. Palin
et al. computed haplotype accuracy of Beagle and Mach1, short-range phasing
algorithms, and of SLRP, a long-range algorithm, and quote switch error rates
on data from the ORCADES cohort (Palin et al., 2011). The long range method
(SLRP) achieved phasing accuracy of 0.036-0.038 phase switches per centiMorgan,
whereas Beagle 0.233-0.625 and Mach1 0.172-0.233 switches per centiMorgan.
The accuracy for all methods dropped as the relatedness of samples decreased.
These results impact accuracy of inferring IBD from resulting haplotypes. If
the switch errors follow the Poisson process with rate 0.625 cM (Beagle), the
probability of a 2 cM region free from switch errors is 0.29. To detect IBD region
of size 2 cM both haplotypes have to be switch error free, the probability of which
is 0.08. When detecting IBD using short-range methods without accounting for
switch errors, many segments would be missed. It is therefore clear that when
searching for longer segments using short-range methods possible switch errors
need to be taken into account. Long-range methods, such as SLRP, are more
appropriate for finding IBD segments.
5.4 IBD analysis in future
Rise and growth of biobanks that store genetic data may be the driving force
for development of new methods for analysis, for example using IBD segments.
Only with high sampling fraction of the population can we find many relatively
recent common ancestors. Expected number of haplotype sharers is proportional
to average kinship in population and number of samples. The population history,
size and number of Iceland is an ideal situation: out currently living 316000
inhabitants of the isolated population, 36000 were genotyped. Similar efforts are
now undertaken in the UK, where similar biobanks are being built: for example
Generation Scotland or the announced sequencing of whole-genomes from 100000
individuals in Britain (Prime Minister’s Office, 2013).
As sizes of the biobanks grow, more important become scalability of algo-
rithms for data analysis. The algorithm of ANCHAP we presented, as well as
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many other algorithms require computation time of the order n2, where n is the
number of samples. Our algorithm, and many others, could be optimised to linear
complexity by using heuristics. For each individual, the analysis could include
only a fixed number of closest related individuals. Closest-related individuals
could be extracted from genetic relatedness computed as correlations of genome-
wide SNP genotypes. Computation of such a relatedness matrix would still have
to be optimised as computed naively, the time required still scales quadratically.
Another technological change is the shift from SNP genotyping technology to
next-generation sequencing. The advantages of next generation sequencing is that
they reveal all variants in DNA, and imputations would be no longer necessary.
Because next-generation reads are from one chromosome each, this information
can be also used to help phasing (Menelaou and Marchini, 2013). While the costs
of next generation sequencing is still significant, combining array data with low-
coverage sequencing data could be a cost-efficient option. As genotyping errors in
next-generation sequencing are more common than in array data, the algorithms
for detecting IBD will necessarily have to handle genotyping errors.
We can hypothesise what we could do had next-generation sequencing been
available for the colon cancer patients and Lynch syndrome carriers in Chapter 4.
Detecting unsuspected carriers of Lynch syndrome would involve only searching
for known mutations in the known mismatch-repair genes. However, for discov-
ering novel mutations the IBD algorithms would still be useful. When we see a
novel variant, and the person carrying it shares IBD at a mismatch-repair gene
with other affected carriers, the variant is likely very harmful as the co-inheritance
of the same haplotype by chance is unlikely. The same idea can be used when de-
tecting new genes associated with the syndrome: frequent IBD sharing of affected
patients at a locus is unlikely by chance.
There are also other possible applications of IBD segments not mentioned in
the thesis, one of which is searching for genes associated with idiosyncratic drug
reactions. Because such reactions can only be detected among patients who were
given a drug, the inheritance pattern is often missed. As a consequence, linkage
studies would not be appropriate for identifying the responsible variants. With
IBD analysis, we may detect distant relatives affected. We may attempt to map
the susceptibility genes by noting loci in the genome where haplotype sharing is
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more common than elsewhere. A key advantage of this method is that it would
allow prediction of the severity of the disease phenotype, based on phenotypes of
the haplotype sharers.
In summary, IBD analysis will require development of large biobanks, al-
gorithm improvement and adjustment to data from next-generation sequencing.
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